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Diabetes mellitus (DM) is a metabolic disorder that causes abnormal blood glucose (BG) regulation that might result 
in short and long-term health complications and even death if not properly managed. Currently, there is no cure for 
diabetes. However, self-management of the disease, especially keeping BG in the recommended range, is central to 
the treatment. This includes actively tracking BG levels and managing physical activity, diet, and insulin intake. The 
recent advancements in diabetes technologies and self-management applications have made it easier for patients to 
have more access to relevant data. In this regard, the development of an artificial pancreas (a closed-loop system), 
personalized decision systems, and BG event alarms are becoming more apparent than ever. Techniques such as 
predicting BG (modeling of a personalized profile), and modeling BG dynamics are central to the development of 
these diabetes management technologies. The increased availability of sufficient patient historical data has paved the 
way for the introduction of machine learning and its application for intelligent and improved systems for diabetes 
management. The capability of machine learning to solve complex tasks with dynamic environment and knowledge 
has contributed to its success in diabetes research.  
Motivation  
Recently, machine learning and data mining have become popular, with their expanding application in diabetes 
research and within BG prediction services in particular. Despite the increasing and expanding popularity of machine 
learning applications in BG prediction services, updated reviews that map and materialize the current trends in 
modeling options and strategies are lacking within the context of BG prediction (modeling of personalized profile) in 
type 1 diabetes. 
Objective 
The objective of this review is to develop a compact guide regarding modeling options and strategies of machine 
learning and a hybrid system focusing on the prediction of BG dynamics in type 1 diabetes. The review covers machine 
learning approaches pertinent to the controller of an artificial pancreas (closed-loop systems), modeling of 
personalized profiles, personalized decision support systems, and BG alarm event applications. Generally, the 





A rigorous literature review was conducted between August 2017 and February 2018 through various online databases, 
including Google Scholar, PubMed, ScienceDirect, and others. Additionally, peer-reviewed journals and articles were 
considered. Relevant studies were first identified by reviewing the title, keywords, and abstracts as preliminary filters 
with our selection criteria, and then we reviewed the full texts of the articles that were found relevant. Information 
from the selected literature was extracted based on predefined categories, which were based on previous research and 
further elaborated through brainstorming among the authors.  
Results  
The initial search was done by analyzing the title, abstract, and keywords. A total of 624 papers were retrieved from 
DBLP Computer Science (25), Diabetes Technology and Therapeutics (31), Google Scholar (193), IEEE (267), 
Journal of Diabetes Science and Technology (31), PubMed/Medline (27), and ScienceDirect (50). After removing 
duplicates from the list, 417 records remained. Then, we independently assessed and screened the articles based on 
the inclusion and exclusion criteria, which eliminated another 204 papers, leaving 213 relevant papers. After a full-
text assessment, 55 articles were left, which were critically analyzed. The inter-rater agreement was measured using 
a Cohen Kappa test, and disagreements were resolved through discussion. 
Conclusion  
Due to the complexity of BG dynamics, it remains difficult to achieve a universal model that produces an accurate 
prediction in every circumstance (i.e., hypo/eu/hyperglycemia events). Recently, machine learning techniques have 
received wider attention and increased popularity in diabetes research in general and BG prediction in particular, 
coupled with the ever-growing availability of a self-collected health data. The state-of-the-art demonstrates that 
various machine learning techniques have been tested to predict BG, such as recurrent neural networks, feed-forward 
neural networks, support vector machines, self-organizing maps, the Gaussian process, genetic algorithm and 
programs, deep neural networks, and others, using various group of input parameters and training algorithms. The 
main limitation of the current approaches is the lack of a well-defined approach to estimate carbohydrate intake, which 
is mainly done manually by individual users and is prone to an error that can severely affect the predictive 
performance. Moreover, a universal approach has not been established to estimate and quantify the approximate effect 
of physical activities, stress, and infections on the BG level. No researchers have assessed model predictive 
performance during stress and infection incidences in a free-living condition, which should be considered in future 
studies. Furthermore, a little has been done regarding model portability that can capture inter- and intra-variability 
among patients. It seems that the effect of time lags between the CGM readings and the actual BG levels is not well 
covered. However, in general, we foresee that these developments might foster the advancement of next-generation 
BG prediction algorithms, which will make a great contribution in the effort to develop the long–awaited, so-called 
artificial pancreas (a closed-loop system).  
1. Introduction 
Diabetes mellitus (DM) is a chronic metabolic disorder that results in abnormal blood glucose (BG) regulation, mostly 
either due to the failure of the body to secrete insulin (Type I) or the inability of the body to respond to insulin action 
(type II). People with diabetes are prone to an increased morbidity and mortality rate as compared to the normal 
population [1]. Regardless of its current prevalence and burden (415 million adults), the number of adults with diabetes 
is projected to reach 642 million by 2040 [2]. Apart from financial and other burdens faced by individual patients and 
families, countries and national health systems are substantially impacted, spending between 5% and 20% of their 
total health expenditure. For example, Solli et al. [3] estimated Norway’s total expenditure, excluding secondary 
diagnoses, to be €293 million in 2005, representing about 1.4% of the total healthcare expenditures. According to 
Skrivarhaug et al. [4], the average incidence rate of type 1 diabetes per 100,000 person years in Norway was estimated 
to be 22.6 (95%, CI 21.4, 23.7) between 1989 and 1996; 28.4 (95%, CI 27.3, 29.6) between 1996 and 2004; and 32.7 
(95%, CI 31.5, 34.0) between 2004 to 2012, justifying a slight increase every seven years, which shows the increasing 
coast of the national health expenditure associated with diabetes [4]. Moreover, the total cost of diagnosed diabetes in 
2012 in the United States was estimated to be $245 billion, including $176 billion in direct medical costs and $69 
billion in reduced productivity [5]. The complexity of diabetes prognosis and management has opened a way for 
artificial intelligence (AI) and machine learning techniques to become key technologies that provide solutions and 
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empower both diabetes patients and their healthcare givers in their everyday lives [6], which in turn have a great 
potential in minimizing the individual, social, and economic burden of the nation. Recently, in line with this trend, 
many publicly funded AI research projects have been carried out, including EMPOWER, MOBIGUIDE, 
COMMODITY12 EU, DIADVISOR, DIABEO, and PEPPER to help diabetic individuals [6].  
Recently, the introduction of quantified-self, which aims to empower patients to make decisions about their own health 
condition through health data collection and documentation, has led to the rapid integration and use of wearable tools 
and sensors, point of care (POC) devices, and other body area networks for physiological monitoring and other health-
related purposes [7, 8]. This has resulted in the accumulation of big personal health data that grow on a daily basis 
[9], which has created opportunities for further analysis of these data to capture relevant information for better self-
monitoring, self-management, and treatments through different AI techniques [9, 10]. Recently, machine learning 
techniques—due to their adaptive nature in a world with dynamic environments and knowledge—have been successful 
at solving complex tasks that are difficult to model with other classical approaches. Machine learning and data mining 
strategies have become increasingly popular with their expanding application in general and within diabetes research 
in particular. Despite machine learning applications’ increasing and expanding popularity in diabetes research in 
general and in BG prediction and dynamics modeling in particular, updated reviews that materialize the current trends 
in modeling options and strategies in the context of personalized BG prediction are lacking. However, several other 
reviews have been conducted on BG prediction and other techniques [11-13]. For example, Oviedo et al. [12] 
conducted a methodological review regarding the prediction models of BG levels, risks, and events. The reviewers 
assessed physiological models, data-driven models, and a hybrid approach, and their experimental setup and 
performance metrics were mainly focused on a closed-loop system (an artificial pancreas) [12]. Moreover, 
Zarkogianni et al. [13] carried out a critical literature review to pinpoint emerging technologies for diabetes 
management and advances, mainly focusing on sensors for physiological and lifestyle monitoring, models, and 
molecular biomarkers for predicting the onset and assessing the progress of DM and on modeling and control methods 
for regulating BG levels [13]. Furthermore, Kavakiotis et al. [11] performed a systematic review of machine learning 
and data mining techniques in diabetes research in the context of diabetes prediction and diagnosis, diabetes 
complications, genetic background and environment, and healthcare and management. Therefore, the objective of this 
review is to develop a compact guide regarding the modeling options and strategies of machine learning applications 
and a hybrid system focusing on BG prediction and modeling of personalized BG profiles in type 1 diabetes. The 
review covers the machine learning approaches that are pertinent to artificial pancreas controllers (closed-loop 
systems), models of personalized profile, personalized decision support systems, and BG alarm event applications. 
Generally, the reviewers will identify, assess, analyze, and discuss the current trends of machine learning applications 
for BG prediction in type 1 diabetes.  
2. Machine Learning-based Data Mining Tasks for Type 1 Diabetes  
The ubiquitous nature and widespread use of mobile health applications (mHealth apps), sensors, wearables, and POC 
devices for self-monitoring and management purposes have made possible the generation of automated and continuous 
personal data, which created the opportunity to use such collected personal data for the modeling of an artificial 
pancreas (a closed-loop system), a personalized BG profile, personalized decision support systems, and BG alarm 
event applications through data mining and machine learning techniques. Data mining approaches could be 
categorized as descriptive or unsupervised (i.e., clustering, association, and summarization) and predictive or 
supervised learning (i.e., classification and regression) [14]. In this regard, the most widely used machine learning 
based data mining tasks in the literatures are BG anomalies detection, BG prediction, and BG dynamics and decision 
making/education models, as shown in Figure 1. The scope of this review is mainly on BG prediction techniques 
focusing on different classes of machine learning algorithms, artificial neural networks, support vector machines, 
Bayesian neural networks, decision trees, and others. It should be noted that reinforcement learning is not under the 
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Figure 1: Most widely used machine learning-based data mining tasks, based on self-recorded data from people with 
type 1 diabetes (modified version of Figure 2 in [14]). The green ellipses indicate the scope of this review.  
2.1. Blood Glucose Prediction  
BG prediction involves forecasting an individual’s BG levels based on past and current history (data) of the patient, 
mainly to provide the necessary alarm so as to avoid any further complications from hypoglycemia and hyperglycemia. 
Numerous factors can directly affect BG levels, among which the history of BG values, insulin, physical activity, and 
dietary intakes are the prominent ones. Moreover, they are also affected by other factors, such as an individual’s body 
mass index, stress level, amount of sleeping time, presence of illness, medications, smoking habit, periods 
(menstruation), alcoholism, allergies, and altitude. An ideal BG predictor should incorporate as much information as 
possible to effectively track and predict BG levels, as shown in Figure 2 [15]. BG prediction approaches are broadly 
classified into three major categories: physiology based (knowledge based), data driven (empirical based), and hybrid 
(hybrid of the two), as shown in Figure 3 [12]. A physiology-based approach entirely relies on the individual’s 
underlying physiological mechanisms and requires extensive knowledge of each underlying mechanism. It divides the 
individual BG metabolism into three different regulatory compartments: BG dynamics, insulin dynamics, and meal 
absorption dynamics [12] and uses various mathematical (differential) equations and probabilistic frameworks to 
model each compartment. The physiology-based approach is mainly categorized into two: the lumped (semi-
empirical) model and the comprehensive model. The lumped model consists of fewer equations and parameters 
compared to the comprehensive model since most of the organs and tissues are lumped together. However, the 
comprehensive model is more complex because it considers various organs and tissues separately [16].  
 
Figure 2: An ideal blood glucose predictor (Reprinted from [15]). 
Blood Glucose Dynamics       
Model    
             BG  Prediction                                                                
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Unlike the physiology-based approach, the data-driven approach uses the individual’s self-recorded historical data 
and requires little understanding of the underlying physiological mechanism; hence, it is commonly known as the 
black box approach [16]. Generally, it could be divided into three different models: a time series model, machine 
learning model, and hybrid model. Therefore, it is the purpose of this review to explore, assess, and analyze the state-
of-the art machine learning techniques and the hybrid approach for BG prediction. 
 
Figure 3: Taxonomy of blood glucose prediction approaches. 
3. Method  
The objective of this review is to develop a compact guide regarding modeling options and strategies of machine 
learning applications and a hybrid system focusing on BG prediction in type 1 diabetes. The review covers machine 
learning approaches pertinent to the controller of an artificial pancreas (closed-loop systems), modeling of a 
personalized profile, personalized decision-support systems, and BG alarm event applications. For the purpose of the 
study, a rigorous literature search was conducted between August 2017 and February 2018, through various online 
databases, including Google Scholar, IEEE Xplore, DBLP Computer Science Bibliography, ScienceDirect, 
PubMed/Medline, Journal of Diabetes Science and Technology, and Diabetes Technology & Therapeutics. Moreover, 
a reference list of the selected articles was used to extract additional articles to get a complete overview of the field. 
Peer-reviewed journals, articles, and conference proceedings published between 2000 and 2018 were considered. The 
inclusion and exclusion criteria were set up through rigorous discussions and brainstorming among the authors. 
Different combinations of the terms “prediction,” “forecasting,” “controller of artificial pancreas,” “diabetes,” 
“intelligent system,” “hybrid system,” “machine learning,” “BG event alarm,” “blood glucose control,” “BG 
personalized decision system,” “clinical,” “closed-loop system,” and “personalized profile” were used during the 
search. The terms were combined using “AND” and “OR” for a better searching strategy. The relevant articles were 
first identified by reviewing the title, keywords, and abstracts for a preliminary filter with our selection criteria, and 
then full text articles that seemed relevant were reviewed. Information from the selected literature was extracted based 
on some predefined categories, which were based on previous research and further refined through brainstorming 
sessions among the authors. 
3.1. Inclusion and Exclusion Criteria  
To be included in the study, the article should develop, test, and discuss machine learning and any of its hybrid 
algorithms in type 1 diabetes, focusing on the modeling of BG prediction. Therefore, studies that reside outside of 
these stated scopes are excluded from the review, including all articles written in languages other than English. 
3.2. Data Categorization and Data Collection  
Information was extracted from the selected articles based on the predefined parameters (variables) and categories. 
The categories were defined based on rigorous brainstorming and discussions among the authors. These categories 
were demarcated solely to collect the relevant data and to assess, analyze, and evaluate the model’s characteristics and 
its experimental setup. 
Age and Number of Subjects: This category was defined to assess, analyze, and evaluate the number of subjects 
involved in the algorithm development, thereby quantifying the level of algorithmic validity.  










Type of Input: This category was defined to assess, analyze, and evaluate the type of inputs used to develop the 
prediction algorithm. This includes the key diabetes parameters such as BG, insulin injection, physical activity, dietary 
information, and others. 
Data Format or Type/Data Source/Data Size: This category is defined to assess, analyze, and evaluate the type of 
data format used as input to the prediction algorithm. This depends on the data sources (i.e., the type of diabetes 
technologies, mobile application, and others) used for data collection and algorithm development. The data can be 
from simulated in silico or in vivo (real) patients. It includes different data formats, such as continuous glucose 
monitoring devices (i.e. CGM), BG simulators (i.e., PADOVA), and m-Health applications (i.e., a diabetes diary) and 
others. 
Input Preprocessing: This category defines the kind of preprocessing that the algorithm implements to avoid missing, 
sparse, and corrupted input data.  
Class of Machine Learning: This category defines the class of machine learning algorithm used to train and test the 
prediction. It includes different classes of machine learning algorithms: artificial neural networks, support vector 
machines, Bayesian neural network, decision trees, and others. 
Training/Learning Algorithm: This category defines the class of learning algorithms used to train the prediction 
algorithms. It includes different training algorithms, such as the back-propagation algorithms, kernels, optimization 
techniques, and others. 
Validation techniques: This category defines the kind of validation approaches used to validate the model during 
training. This includes holdout, random subsampling, k-fold cross-validation, and others.  
Prediction Horizon (PH): This category defines the extent of the lead time in which the prediction can be executed 
with the developed system. It shows how long the future BG can be predicted without losing considerable accuracy 
as compared with the individual’s BG dynamics.  
Performance Metrics/Evaluation Criteria: This category defines the type of evaluation metrics used to determine the 
accuracy of the implemented prediction algorithm. It includes different performance metrics such as mean square error 
(MSE), error grid analysis, and others. 
3.3. Literature Evaluation   
The evaluation and analysis of the literature were based on the categories and variables defined above to pinpoint the 
state-of-the art machine learning-based BG prediction techniques and their associated characteristics along with the 
experimental setups. The first analysis was conducted based on data characteristics and the type of input the prediction 
algorithms have used to reveal the state-of-the art inputs used in BG prediction. The second analysis was conducted 
based on the type of machine learning used in the algorithm development to pinpoint the most adopted class of machine 
learning in this specific task. The final analysis was conducted based on the performance metrics used to evaluate the 
performance of the developed system. This analysis will reveal important information regarding the available 
performance metrics to choose from, which is usually a confusing and difficult process, given the large number of 
performance metrics.  
4. Results  
4.1. Relevant Literature 
The initial hit was vetted using the title, abstract, and keywords and retrieved a total of 624 papers from DBLP 
Computer Science (25), Diabetes Technology and Therapeutics (31), Google Scholar (193), IEEE (267), Journal of 
Diabetes Science and Technology (31), PubMed/Medline (27), and ScienceDirect (50). After removing duplicates 
from the list, 417 records remained. Then, we independently assessed the articles and screened them based on the 
inclusion and exclusion criteria, which eliminated another 204 papers, leaving 213 relevant papers. After a full-text 
assessment, 55 articles were left, which were critically analyzed, as shown in Figures 4 and 5 and Tables 1 and 2. The 





















Figure 5: Diagram of the review process. 
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Table 1: Number of subjects used, data source, class of machine learning, prediction horizon, performance metrics 
and others information extracted from the literatures included in the study. 
Ref. Subject Type of input Data Format/Data 
source 
Input Pre-processing Class of Machine Learning Prediction 
Horizon (PH) 
Performance Metrics 
[17] 9 Blood Glucose (BG) Guardian Real Time CGM 
(Medtronic-Minimed) 
Smoothing (LPF of order 11) Recurrent neural network (RNN) 15, 30, 45, 60 min Root Mean Squared Error 
(RMSE), FIT, Normalized 
Prediction Error (NPE), Clarke 
Error Grid approach (CEGA) 
[18] 9 Blood Glucose (BG) Guardian Real Time CGM 
(Medtronic Minimed) 
Smoothing (LPF), noise and time 
lag reduction 
Feed forward neural network model  15, 30, 45 min RMSE, FIT, NPE, CEGA 
[19] 1 BG, Insulin, diet, exercise, 
stress, 
Data collected Manually 
N/A Radial-basis function (RBF) network N/A RMSE 
[20] 5 CGM, insulins, diet N/A Filtering-Extended Kalman filter Support Vector Regression- Gaussian kernel 30, 60 min RMSE, expert references 
[21] 
N/A N/A N/A N/A 
Layer Recurrent Network (LRN), Elman net, and 
Nonlinear Autoregressive Neural Network with 
external input (NARX-net) 
20, 40, 60, 80, 




[22] 30 in 
silico 
BG, Insulin, diet UVA/Padova simulator Normalization  Online (real time) & adaptive Recurrent Neural 
network (RNN) 
30 and 45 min Continuous Glucose-Error 
Grid Analysis (CG-EGA), 






BG, Insulin, diet UVA/Padova, FreeStyle 
Navigator CGM 
Scaling, adding a noise on the 
CGM using AR first order and 
Gaussian noise 
Hybrid (Feed forward Neural network plus linear 




RMSE, Temporal Gain (TG), 
Energy of the Second-Order 
Differences (ESOD), Index J 
[25] & 
[15] 
20 real BG, derivative of BG, diet Dexcom SEVEN PLUS 
CGM 
Normalization, Scaling,  
Bayesian smoothing 
Hybrid (Jump neural network along with 
physiological model) 
30 min RMSE, average TG, ESOD 
[26] 10 real BG, change in BG, physical 
activities 
Guardian real-time CGM, 
SenseWear Armband 
Normalization, quantizing input 
space 
Feed forward neural network (FNN), a self-
organizing map (SOM), a neuro-fuzzy network with 
wavelets as activation functions (WFNN), linear 
regression model (LRM), 
 
30, 60 and 120 
min 
RMSE, Correlation 
Coefficient (CC), Mean 
Absolute Relative Difference 
(MARD), and CG-EGA 
[27] 6 real BG, change of BG, physical 
activity 
Guardian real-time CGM 
SenseWear Armband 
Normalization  Neuro-fuzzy model with wavelet activation 
functions (WFNN)- Gaussian functions as 
membership function 
15, 30, 45, 60 min RMSE, CC, MARD, and CG-
EGA 
[28] 12 real BG, Insulin, diet Insulin pumps and CGMS 
(First Department of 
Pediatrics, P&A Kyriakou 
Children’s Hospital, Athens) 
N/A 
Hybrid-Compartmental model (MM)) and self-
organizing map (SOM) - Vector Quantization 
Method 
30 and 60 min RMSE, CC, and CG-EGA 
[29] 1 real BG, Insulin, diet, exercise, 
stress, 
Delft University of 
Technology 
Feature extraction using 
principal component analysis 
Wavelet Neural Network Interval RMSE 
[30] 7,109 
users 
17 medical examination 
items 
4 years Medical examination 
database 
Feature extraction-random forest 
with importance score. Feature 
selection-Sequential Backward 
Selection (SBS) algorithm 
Support vector machine (SVM) and random forest 
N/A 
ROC, Mean Absolute Error 
(MAE) and RMSE 
[31] 10 real BG JDRF CGM Study Group 
N/A 
Ensemble approach Hybrid-fusion (AR, extreme 
learning machine, and support vector regression- 
kernel function (Gaussian)) 
15, 30 and 45 min RMSE, relative error, CEGA, 
and J index. 
[32] 10 real BG, Insulin, exercise, diet, 
others 
Automatic electronic 
recording device & paper 
records 
N/A 





6 real BG, Insulin, exercise, diet Abbott Freestyle and the 
Dexcom Seven Plus N/A 
Ensemble approach (state-space-based model (SS), 
a recursive ARX model and a kernel-based 
predictor) 
40 min CEGA, RMSE 
[35] 10 real BG Abbott Freestyle and the 
Dexcom Seven Plus 
Data transformation Kernel-function- Fully Adaptive 
Regularized Learning (FARL) 




4 real BG, Insulin Self-Monitoring Blood 
Glucose (SMBG) - One 
Touch Ultra® glucometer, 
Medtronic CGMS 
Smoothened using cubic splines 
Interpolation. De-noising with 
extended Kalman filter algorithm 
Feature based Feed-forward Neural Network (FNN) 30,45 and 60 min RMSE and Time delay 
[38] & 
[39] 
2 real, 1 
in silico 
Time, Diet, Insulin, BG, 
illness, stress, pregnancy 
Diabetes simulator, Diabetic 
Outpatient Department of 
Glasgow's Royal Infirmary 
N/A 
Elman Recurrent Neural Network 1, 2, 4, 8 hours Average error  
[40] 1 in silico BG, diet, insulin Diabetes simulator, AIDA 
N/A 
Elman recurrent artificial neural networks (ANNs) 15, 30, 45, and 60 





[41] 5 in silico BG Simulator program 
(www.2aida.net) and a CGM 
system - FreeStyle Libre 
Cubic spline interpolation, 
scaling  
Support Vector Regression (SVR)- Radial basis 
function (RBF) as kernel 
 
30 and 60 min 
Arithmetic mean of the relative 
error 
[42] 10 real BG, time, insulin, exercise, 
diet, Stress level 
N/A 
Normalization, renormalization Feed-forward neural networks (MLP), Elman 
Recurrent Neural Network 
N/A N/A 
[43] 5 real BG, diet. Insulin 
N/A 
Extended Kalman filter, ARIMA Hybrid (Generic physiological model & Support 
Vector Regression- Gaussian kernel) 
30 and 60 min RMSE, expert references 
[44] 15 real BG Medtronic Guardian,  Abbott  
Navigator 
Noise pre-filtering- causal 
Kalman filtering method. cubic 
spline to recover missing 
samples 
Feed-forward neural network model 15, 30 and 45 min RMSE and prediction delay 




CGMS Gold Medtronic 
N/A 
Feed-forward neural network model  
75 min 
CEGA, RMSE and Mean 








Medtronic CGM, electronic 
diary 
N/A 
Time-lagged feed-forward neural networks, Genetic 
algorithm- Determining Optimal step sizes and 
momentum values for the minimization of error 
50, 75, 100, 120, 
150 and 180 min 
MAD% 
[48] 5 real Time, BG, and Electronic 
Medical Records data 
Medtronic CGMS Normalization Feed-forward Neural Network 75 min CEGA, Overall error (MAD%) 
[49] 1 real BG, insulin, diet, exercise 
N/A 
Fuzzy approximation of food, 
exercise 
Hybrid- (Compartmental Model & Feed-forward 
neural network, fuzzy logic, and expert system) N/A 
Mean percent error (MPE) and 




[50] 4 real BG, insulin, diet Medtronic MiniMed 
N/A 
Hybrid – (Compartmental model & Feed Forward 
Neural Network, Recurrent Neural Network) 
N/A 
RMSE, CC 
[51] 1 real Time, BG, insulin injection, 
diet 
Diary data Normalization Hybrid- (Compartmental Models (CMs) and 
Recurrent NN (RNN)) 
15 min RMSE, CC, MAD%, Standard 
Deviation (SD) 
[52] 25 real BG, Rate of change in BG DirectNet Central 
Laboratory 
Normalization, smoothing (1-
order Butterworth filter) 
Deep Neural Network-classical radial basis function 




[53] 2 real BG, Insulin, diet, exercise Medtronic Paradigm 522 
insulin pump and CGMs, 
diary 
Normalization Adaptive network-based fuzzy inference system 
(ANFIS)- triangular & Linear membership 
function        
120 min Average error of prediction 
[54] 70 real BG, insulin, diet, exercise, 
sleep, hypoglycemic 
symptoms 
Smartphone diary pooled panel data (PPD) 
regression - Clustering  
 
Support vector machine (SVM), Decision tree, 
random forest N/A 
MAE, RMSE, and coefficient 
of determination 
[55] 4 in silico, 
3 real 
BG AIDA simulator, Dexcom 
SEVEN 
N/A 
Hybrid- (Genetic Algorithms (GA) and 
Compartmental Model) 
30 min N/A 
[56] 6 real BG, insulin, diet, physical 
activity 
Dexcom G4 Platinum CGM, 
Paradigm Veo - 754 insulin 
pumps, mylife Omnipod 
insulin pumps, AccuChek 
insulin pump, Fitbit Charge 
HR™ devices 
N/A 
Hybrid-Fused (ARX and Elman simple recurrent 
neural network) for prediction and Extreme 
Learning Machine for correction 
15, 30 and 45 min RMSE, CC and TL 
[57] 15 real BG, Insulin, diet, physical 
activity 
Guardian Real-Time CGM, 
SenseWear Armband, paper 
diary N/A 
Single hidden layer feedforward neural networks - 
(kernel RLS, Gaussian kernel)-Extreme Learning 
Machine  
 
30 min RMSE, TG, ESOD 
[58] 15 real BG, Insulin, diet, physical 
activity 
Guardian Real-Time CGM, 
SenseWear Armband, paper 
diary 
Ranking feature set- Random 
forests (RF) and RReliefF 
algorithms, bootstrap resampling 
Support vector regression- radial basis function or 
Gaussian processes 
30 and 60 min Average RMSE 
[59] 27 Time, BG, insulin, Physical 
activity 
 
Guardian Real-Time CGM, 
SenseWear Armband, paper 
diary 
N/A 
Hybrid- (Random Forests regression technique & 
compartmental model) 







2 real BG, Insulin, diet, physical 
activity 
Guardian Real-Time CGM, 
SenseWear Armband, paper 
diary N/A 
 
Hybrid- (Support Vector machines- linear kernel 
and Compartmental model) 




[64] 20 real BG, Insulin, diet, physical 
activity 
Medtronic Minimed 
Guardian Real-Time system N/A 
Feedforward neural networks-multilayer perceptron 
N/A 
RMSE, normalized RMSE, CC 
[65] 25 in 
silico 
BG GlucoSim software Digital Noise filtering 
techniques-Kalman filter 
Time-lagged feed-forward NN 60 and 120 min MAD% 
[66] 18 real BG, Insulin, diet, Heat flux, 
skin temperature, and METs 
(Metabolic Equivalent) 
SenseWear Pro 2 armband, 
Guardian CGMS, food and 
insulin diary 
N/A Gaussian Processes (GPs)- Bayesian framework 25 min, 1 hour 





23 real BG and insulin Medtronic insulin pumps, 
real-time CGM system 
Smoothening and Filtering Hybrid-Fused (autoregressive model with output 
correction – cARX, & recurrent neural network – 
RNN)-Data fusion (Genetic Algorithms (GA), & 
Genetic Programming (GP)) 
15, 30 and 45 
min 
RMSE, time lag (TL), and CC 
[69] 10 real BG, insulin, diet Medtronic CGMs Feature reduction through 
averaging 
K-nearest neighbors regression, Random forest 
regression, Hybrid- (Symbolic regression by tree-
based genetic programming & compartment 
models) 








BG, insulin, diet UVA/Padova T1D simulator 
N/A 
Hybrid (Genetic Programming-Grammatical 
Evolution & Physiological model) N/A 
CEGA, RMSE, Mean absolute 
deviation (MAD), & MARD 
[72] 17 real BG Guardian CGM system Stationarity & autocorrelation 
test- Augmented Dickey-Fuller 
(ADF)  
Autoregressive neural network (AR-NN) 30, 60 and 90 min Mean absolute error (MAE), 
and RMSE 
[73] 1 real BG, insulin, diet Paradigm Real-time Insulin 
Pump, MiniMed CGM N/A 
Recurrent neural network - Neural Network 
Autoregressive external input, Recurrent Multilayer 
Perceptron (RMLP) 
N/A N/A 
[74] 1 real Times, insulin, diet, 
exercise, BG N/A N/A 
Hybrid-(Recurrent neural network & 
Compartmental model), neuro-fuzzy time series 
models 
N/A 
The explained variance as a 
function of mean squared 
prediction error  
[75] 2 real BG, insulin, exercise, diet Guardian Real-Time CGMS, 
SenseWear Body Monitoring 
System armband, diet 
manually collected by the 
patient  
N/A 
Hybrid-(Compartmental model & Support Vector 
Regression- linear kernel) 
15, 30, 60 and 120 
min 
RMSE , CC, CEGA 
[76, 
77] 
5 in silico, 
8 in silico 
BG, diet, insulin AIDA simulator 
N/A 
Genetic programming-Grammatical Evolution (GE) 
N/A 
Mean percentage average 
error, CEGA 
[78] 10 real BG, Insulin, diet 
N/A Scaling and normalization, 
interpolation of missing values 
Recurrent neural network (RNN) 30, and 60 min RMSE 
[79] 1 real BG, insulin, diet Paradigm Real-time 
Monitoring (CGM & Insulin 
Pump)  
N/A 
Neural Network Autoregressive external input 
(NNARX), Recurrent multilayer perceptron neural 
network  
N/A 
Mean Square Error (MSE) and 
absolute error 
[28] 12 real BG, insulin,  diet insulin pumps and CGMS 
(Diabetes Centre, First 
Department of Pediatrics, 
P&A Kyriakou Children’s 
Hospital, Athens) 
N/A 
Hybrid- (Compartmental Models (CMs) and a Self-
Organizing Map (SOM) - Vector Quantization 
Method) 
30 and 60 min RMSE, CC, CG-EGA 
[80] 
 




Support vector regression (SVR) based on 
differential evolution (DE) algorithms 
15 min, 30 min, 
45 min and 60 
min 
Root mean square error 
(RMSE), the mean absolute 
percentage error (MAPE) and 
the fitness degree (R2). 
[81] 13 real BG 
Freestyle Navigator CGM 
System (Abbott 
Laboratories). 
Spline interpolation method was 
used to overcome missing 
records 
Feed forward Artificial Neural Networks (ANN) 
15 min, 30 min, 
45 min and 60 
min 
Root Mean Square Error 
(RMSE), Mean Absolute 
Percentage Error (MAPE), 
Fitness degree R2, the Relative 
Error Analysis (REA), Sum of 
Squares of Glucose Prediction 
Errors (SSGPE), CEGA. 
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Table 2: Subject age group, data size and validation approach used for development, and reported model 
performance extracted from the literatures. 
Ref Subject Age 
Group 
Data size (Training, Validation & 
Testing) 
Validation Approach Mathematical Accuracy Clinical Accuracy 
[17] N/A 
The average duration of glucose measurements for each 
patient is 2 days, 288 samples for each day 
Random subsampling: Data set consists of 4916 samples 
(4416 samples used to train, 500 samples used to test and 
validate)  
 
15 min (FIT (%)-95.33, RMSE (mmol/L) - 0.14, NPE (%)-1.7), 
30 min (FIT (%)-85.83, RMSE (mmol/L)- 0.42, NPE (%)-5.27), 
45 min (FIT (%)-72.3, RMSE (mmol/L)- 0.84, NPE (%)-10.28), 
60 min (FIT (%)-56.61, RMSE (mmol/L)- 1.32, NPE (%)-16.2) 
Clarke's EGA:15 min (A- 100, B-0, C-0, D-0, E-
0), 30 min (A- 98.6, B- 1.3, C-0, D-0, E-0),45 
min (A- 91.5, B- 8.4, C-0, D-0, E-0),60 min (A- 
78.7, B- 19.3, C-0, D- 1.95, E-0), 
[18] N/A 
The average duration of glucose measurements for each 
patient is 2 days, 288 samples for each day 
Random subsampling: Data set consists of 4916 samples 
(4416 samples used to train, 500 samples used to test and 
validate)  
 
15 min (FIT (%)-94.68, RMSE (mmol/L) - 0.15, NPE (%)-1.94), 
30 min (FIT (%)-85.5, RMSE (mmol/L)- 0.42 , NPE (%)-5.37), 
45 min (FIT (%)-72.1, RMSE (mmol/L)- 0.83, NPE (%)-10.2) 
Clarke's EGA:15 min (A-100, B-0, C-0, D-0, E-
0), 30 min (A-98.53, B-1.47, C-0, D-0, E-0),45 
min (A-86.7, B-10.5, C-0, D-2.7, E-0) 
[19] N/A 
A continuous period of 77 days from one patient Repeated Hold-out Method: 20 holdout conditions, 
consist of a random distribution (train data set - 40%, 
validation data set - 30% and test data -30%) 
Interval RMSE Validation data–Morning (0.0710), Afternoon 
(0.0491), Evening (0.0263), Night (0.0119) N/A 
[20] 
N/A 
Approximately 1,400 days’ worth of clinical patient data Random subsampling: A total of 200 timestamps in the 
dataset, 40 points per patient were manually selected to 
mimic a diverse set of circumstances. 
N/A 
Physician expert references 
[21] 
N/A 
9 days dataset with 626 vectors  
N/A 
40 min (RMSE-0.313), 50 min (RMSE-0.338), 60 min (RMSE-
0.346)   
N/A 
[22] 
10 adults, 10 
adolescents, and 10 
children 
Data of 8 days derived from a virtual population of 30 
diabetes patients 
Hold-out: The first 4 days per patient were used for 
training, whereas the remaining data were used for 
evaluation 
 
Mean (SD) (30 min- (Adults (RMSE (mg/dL)- 2.8 (0.4)), 
Adolescents (RMSE-3.1 (0.8)), Children (RMSE-4.5 (2.2))), 45 
min- (Adults (RMSE-4.0 (0.7)), Adolescents (RMSE-4.4 (0.8)), 
Children (RMSE -6.3 (3.0)) 
According to the CG-EGA: more than 89% of the 
predictions and 93–94% of the predictions for 
hypoglycemic range were clinically accurate for 
all the patients and PHs.  
[23] & [24] N/A 
Simulated Data: 11 consecutive days of monitoring BG, 
insulin along with 3 meals per day 
 
k-fold cross-validation Mean ± SD:30 min (RMSE (mg/dl) -14±4.1) N/A 
[23] & [24] N/A 
Real Data: Fifteen type-1 diabetic patients were monitored 
for seven consecutive days (meals, carbohydrate intake 
for hypo-corrections, and insulin dosages)  
k-fold cross-validation Mean ± SD:30 min (RMSE (mg/dl) - 9.4±1.5) Time lag (TG) in (min): 24.9 ± 4.4 
[25] & [15] N/A 
20 T1D patients, monitored for 2 or 3 consecutive days 
in real-life conditions. 
k-fold cross-validation (training set constituted by 70 % 
of the data, and the validation set constituted by the 
remaining 30 % of data), Bayesian regularization 
Mean ± SD:30 min (RMSE (mg/dl)-16.6 ± 3.1) 
Time lag (TG) in (min): 18.5 ± 3.4 
[26]  (FFNN) 
7 males and 3 females 
(41.8 ± 14.39 of age) 
Data corresponding to identical number of days (6) for 
each patient were used 
10-fold cross-validation 
Mean ± SD: 30min (RMSE - 13.31 ± 4.47), 60min (RMSE - 
22.66 ± 6.86), 120min (RMSE - 37.62 ± 11.79) 
CG-EGA-Accurate Readings (AR): 30 min 
(hypoglycemia (73.29%), euglycemia (88.46%), 
hyperglycemia (84%) ), 60 min (hypoglycemia 
(54.25%), euglycemia (88.83%), hyperglycemia 
(83.95%) ), 120 min (hypoglycemia (33.65%), 
euglycemia (88.18%), hyperglycemia (82.81%) ) 
[26] (SOM) 
7 males and 3 females 
(41.8 ± 14.39 of age) 
Data corresponding to identical number of days (6) for 
each patient were used 
10-fold cross-validation 
Mean ± SD: 30min (RMSE - 11.42 ± 2.33), 60min (RMSE - 
19.58 ± 3.80), 120min (RMSE - 31.00 ± 6.07) 
CG-EGA-Accurate Readings (AR): 30 min 
(hypoglycemia (91.11%), euglycemia (91.86%), 
hyperglycemia (88.59%)), 60 min 
(hypoglycemia (78.47%), euglycemia (90.45%), 
hyperglycemia (86.96%) ), 120 min 
(hypoglycemia (56.40%), euglycemia (88. 
86%), hyperglycemia (84.73%) ) 
[26]  (WFNN) 
7 males and 3 females 
(41.8 ± 14.39 of age) 
Data corresponding to identical number of days (6) for 
each patient were used 
10-fold cross-validation 
Mean ± SD: 30min (RMSE - 15.22 ± 2.17), 60min (RMSE - 
24.66 ± 3.39), 120min (RMSE - 39.59 ± 5.03) 
CG-EGA-Accurate Readings (AR): 30 min 
(hypoglycemia (76.18%), euglycemia (89.48%), 
hyperglycemia (85.13%) ), 60 min 
(hypoglycemia (64.74%), euglycemia (88.89%), 
hyperglycemia (84.57%) ), 120 min 
(hypoglycemia (51.51%), euglycemia (87.34%), 
hyperglycemia (82.36%) ) 
[27] N/A 
Data from the medical records of 6 T1DM patients for an 
observation period ranging from 7 to 15 days (mean ± 
standard deviation: 10.83 ± 3.86) were used. 
10-fold cross-validation N/A 
CG-EGA- Zones A (15 min (94.35 ± 5.66), 30 
min (86.70 ± 3.76), 45 min (78.08 ± 7.56), 60 
min (71.89 ± 9.33)) 
[28] 
7 male and 5 female 
(19.83 ± 12.28 of age) 
Patients were monitored for a ten-day period. 
Hold-out: 60% of the data for training purposes (model 
development), while the remaining 40% for testing 
(model evaluation)  
30 min (RMSE (mean ± standard deviation (SD): 14.10 ± 4.57) 
and CC (mean ± SD: 0.94 ± 0.02)), 60 min (RMSE (mean ± 
SD: 23.19 ± 6.40) and the CC (mean ± SD: 0.84 ± 0.05)) 
CG-EGA-Accurate Readings (AR): 30 min 
(hypoglycaemia (81.06%), euglycemia 
(92.18%), hyperglycaemia (88.27%) ), 60 min 
(hypoglycaemia (63.22%), euglycemia 
(92.18%), hyperglycaemia (87.19%) ) 
[29] 
N/A 
Dataset from one patient covering a period of 77 days Multi-fold cross validation- (10-fold cross validation) RMSE (Morning (0.0450), Afternoon (0.0348), Evening 
(0.0330), Night (0.0170)) N/A 
[30] 
4,095 males, and 
3,501 females (20-50 
of age) 
4 years medical examination data Random subsampling: 2/3 of the data is training set and 
the rest testing set  
FS-random Forest (AUC(74.92%), RMSE (0.5706), 
MAE(0.3200)), Random Forest (AUC(71.96%), RMSE 
(0.5996),MAE(0.3347)),FS-SVM (AUC(72.19%), RMSE 





CGMS readings of each patient included 860 CGMS data 
points with 5-min sampling period (in total, 4,300 min) 
Hold-out: 60% for training and the rest for testing and 
validation. These first 500 points (2,500 min) for each 
subject were used for training, and the other 360 points 
(1,800 min) are validation data. 
RMSE (mg/dl): 30 min (19.0 ± 0.3) CG-EGA- Zones A: (30 min (85.7±0.3)) 
J Index: (30 min (12.0 ± 2.1)) 
[32] 
N/A 
Each patient’s medical history corresponds to a period 
from 116 (926 observations) to 149 (1327 observations) 
days of measurements. 
Hold-out: 80% for model training and 20% for testing  Mean MAE: 21.5-23 mg/dl N/A 
[33] 
N/A 20 datasets simulated, each 8 days long. Hold-out: One of the 20 datasets was used for training and 
the others were considered test data. 
RMSE [mg/dl]: 60 min (8.1) 
N/A 
[33] & [34] 
3 Men /3 Women, 32–
68 of age 
Each trial ran over three days (Meal and insulin 
administration were noted in a logbook, glucose was 
monitored by Abbott Freestyle (DAQ) and Dexcom Seven 
Plus (DIAdvisor I) CGM systems 
Hold-out: The model was trained on second trail data and 
validated on the third trail data 
Median RMSE/ RMSEbest [Min-Max]: 40 min (1.03 [0.75–
1.04]) 
CG-EGA- Zones A: 40 min (95.5%) 
[35] 
Male and female 
between 18 -70 years 
old 
The DAQ-trial clinical record of nearly 10 days of CGM 
data collected with Abbott’s Freestyle Navigator (Δt = 10 
(min)), and another record of CGM data were collected for 
three days with the use of DexCom SEVEN PLUS ( Δt = 
5 (min)). 
Hold-out: One patient CGM-measurements collected 
during one day of the DAQ-trial with the use of an Abbott 
sensor as learning datasets and the rest for testing  N/A 
CG-EGA- Zones A: 30 min (91.3%), 60 min 
(75.14%), 75 min (68.77%) 
[36] & [37] age10±4 One day (24 hr) data collected through self-monitoring 
blood glucose (SMBG), Medtronic CGMS and other 
sources. 
Random subsampling: 50% of data is used for training, 
25% for validation and 25% for testing  
RMSE (mg/dl): 30 min (10),45 min (15), 60 min (20) 
Time lag in minutes (Mean± SD): 30 min 
(3.2±2), 45 min (4.5±3), 60 min (7.6±4.1),  
[38] & [39] 
15 old girl and 32 old 
pregnant woman 
Both patients regularly monitored and recorded, in a diary, 
their BG, insulin, diet and physical exercise for a 10 days 
period and 122 events in total. 
Hold-out: Most of the data sets were used during training 
(97 events), with only a small number used to evaluate 
performance. 
RMSE (mg/dl): One event-step prediction (27) N/A 
[40] N/A 
For a single patient Twenty-eight days of data were 
produced from AIDA 
Random subsampling: Divide random training 60%, 
validation 20%, and testing 20%)  
15, 30, 45, and 60 minutes (RMSE5day of 0.15 ± 0.04 SD 
mmol/L, and an errormax of 0.27 mmol/L), 8 hr 
(RMSE5day: 0.14 ± 0.16 SD mmol/L, errormax: 0.20 mmol/L), 






Simulated: For each patient, 25 days of BGLs were 
simulated 
Five-fold cross validation Arithmetic mean of the relative error over all samples of one 
day T: 30 minute (0.2-4 %), 60 minute (0.3-7 %) 
N/A 
1 patient CGM data amounted to 4635 readings over a 
period of roughly 35 days 
Five-fold cross validation Arithmetic mean of the relative error over all samples of one 




Woman, ages between 
17 and 26 years 
The recorded data that was used covers a continuous 
period of 75 days for some of patients and 135 days for 
Hold-out: 75% of datasets used to training and the rest 
for testing 






another. For each day we have recorded data just in the 




Woman, ages between 
17 and 26 years 
The recorded data covers a continuous period of 75 days 
for some patients and 135 days for another. For each day 
data recorded just in the morning and afternoon and during 
this interval. 
Hold-out: 75% of datasets used to training and the rest 
for testing 
Mean of prediction Errors: (10.4023 (mg/dl))  
N/A 
[43] N/A 
A database of over 1,600 day worth of clinical data of 
patients 
Random subsampling: an evaluation dataset of 200 
timestamps, 40 points per patient and were manually 
selected to reflect the diverse set of situations the predictor 
would encounter in practice 
RMSE(mg/dl)): 30 min (22.6), 60 min (35.8) 
N/A 
[44] N/A 
The Guardian dataset includes data from nine patients 
wore the CGM intermittently for 72 h/week over a 4-week 
period. The dataset includes 12 daily profiles for every 
patient: six full-day and six half-day recordings. The 
FreeStyle Navigator dataset includes data from six 
patients wore the CGM system for around 72 h. The 
dataset includes two complete daily profiles for every 
patient 
Hold-out: For each dataset, three subjects (each with two 
daily profiles) were used for training the NNM. The 
validation set for the Guardian monitor included six 
patients and six profiles per patient. The validation set for 
the FreeStyle Navigator monitor included three patients 
and two profiles per patient. 
Guardian CGM (RMSE (mean±SD mg/dL):15 min (9.74±2.71), 
30 min (17.45±5.44), 45 min (25.08±8.73)), FreeStyle Navigator 
CGM (RMSE (mean±SD mg/dL): 15 min (10.38±3.15), 30 min 
(19.51±5.53), 45 min (29.07±6.77)) 
Guardian CGM (Delay (mean±SD min): 
Upward-15 min (3.92±1.21), 30 min 
(11.65±4.11), 45 min (16.46±4.79)), Downward-
15 min (5.10±1.65), 30 min (15.92±3.64), 45 min 
(23.82±5.13)), FreeStyle Navigator CGM 
(Delay (mean±SD min): Upward-15 min 
(4.58±1.42), 30 min (7.26±3.34), 45 min 
(11.50±6.85)), Downward-15 min (5.37±2.16), 
30 min (14.56±3.81), 45 min (28.67±4.62)), 
[45] N/A 
Twenty-seven patients’ data recorded using CGM and 
Pocket PC-based electronic diary facilitated 
documentation of insulin dosages, nutritional intake, 
hypoglycemic/ hyperglycemic symptoms, 
lifestyle/activities, and emotional factors. 
Hold-out: Training set that included 23,432 vectors of 
CGM and electronic diary data collected in 17 patients. 
Evaluated using data derived from 10 patients not 
included in the model training set. This test dataset 
included 394.3 h of CGM and electronic diary data. 
75 min (Overall MAD% (22.1), MAD% (non-hypoglycemic) 
(18.1), RMSE (mean±SD mg/dL) (43.9±6.5), RMSE (mean±SD 
mg/dL) (non-hypoglycemic) (43.0±6.4)) 
CG-EGA- 75 min: Zones A (62.3%), Zones 
(30.0%) 
[46] & [47] N/A 
18 patients used CGM for a duration between 3 and 9 days Hold-out: Training sets using 11–17 patients were used to 
generate neural network models. The performance of each 
neural network model was evaluated using the CGM and 
electronic diary data from a patient who was not included 
in the training data    
Overall MAD(%) (50 min (6.7), 75 min (8.9), 100 min (11.7), 
120 min (14.5), 150 min (16.6), 180 min (18.9)) 
N/A 
[48] - A patient 
specific neural 
network model 
38 years old 
283.9 hr (3,407 data points) of CGM and concurrent 
medical records data from a 38 years old trauma patient 
(who had an intensive care stay of 16 days). 
Hold-out: Trained using 243.6 hours (2,923 data points) 
of CGM and medical records data, 40.3 hours [484 data 
points] of CGM and medical records) was used to test the 
performance. 
Overall error (MAD%): 75 min (7.9%) 75 min - CEGA revealed that 95.1% of the 
predictions fell within region A of the error grid 
and 4.9% fell within region B of the error grid. 




556 hr (6,672 data points) of CGM and medical records 
data from 5 critical care patients 
Hold-out: Trained using 515.7 hours (6,188 data points) 
of CGM and medical records data, 40.3 hours [484 data 
points] of CGM and medical records was used to test the 
performance. 
Overall error (MAD%): 75 min (15.9%) 75 min - CEGA revealed that 69.8% of the 
predictions fell within region A of the error grid 




Children (13-22), 2 
female and 2 male 
The patients were monitored for a period between 3 to 5 
days. 
Hold-out: The recorded days have been divided into two 
disjoint datasets: training, and testing sets. For each 
patient, the data of the first days (minimum 3 days) using 
CGMs have formed the training set, and the data of the 
last day using CGMs the testing set. 
RMSE (mg/dl): 7.19 
N/A 





Children (13-22), 2 
female and 2 male 
The patients were monitored for a period between 3 to 5 
days. 
Hold-out: The recorded days have been divided into two 
disjoint datasets: training, and testing sets. For each 
patient, the data of the first days (minimum 3 days) using 
CGMs have formed the training set, and the data of the 




Data from a Type 1 diabetes patient covering a period of 
69 days, have been used as input to the proposed system 
Hold-out: From the available Type 1 diabetes patient data, 
the first 59 days, consisting of 275 glucose measurements, 
have been used in the training set, and the last 10 days, 
with 45 glucose measurements, in the testing set 
On – Line RTRL – FR (RMSE(mg/dl): 41) 





Children less than 18 
years old 
Clinical data set provided by the DirectNet Central 
Laboratory, which lists BG levels of different patients 
taken at 5-min intervals with the CGM device 
Hold-out: Consider the entire data for 30% of the patients 
as training data, and predict the BG level for the remaining 
70% of patients in the data set. 
N/A 
Average PRED-EGA scores (in percent): 
Accuracy - 30 min (Hypoglycemia (86.41), 
Euglycemia (85.05), Hyperglycemia (62.24)) 
[53] N/A 
Data sets from two patients over eight weeks were used to 
prototype, train, and assess the mode. Data from the CGM 
and pump were used in conjunction with a diary of food 
consumed, carbohydrates, exercise type and duration, and 
meal times 
Hold-out: For training, six sets of data containing insulin, 
carbohydrate, exercise level, and time of day were used. 
Each of the data sets contained 24 periods for every 
consequent 5-minute interval for a total duration of two 
hours (24 x 5 = 120 minutes). 
  
Average error of prediction: 30 min (31 mg/dl), 60 min (57 
mg/dl), 120 min (103 mg/dl) 
N/A 
[54] N/A Dataset includes 70 sets of data recorded from the UCI 
Machine Learning Repository 
N/A RMSE (SVM (68.76), DT (41.06), RF (39.73)), MAE (SVM 
(63.097), DT (36.423), RF (37.586)) 
N/A 
[56] 
Age 22-29 years 
Sensor glucose, insulin pump data, food intake, and 
physical activity data from six individuals with T1D 
(HbA1c: 6.83 ± 0.75%; body mass index: 24.79 ± 4.71 
kg/m2) under sensor-augmented pump (SAP) therapy 
Hold-out: Data 48 h prior to the exercise intervention were 
used for training purposes, while data 35 h after the 
intervention were used for evaluation 
RMSE(mg/dl)): Mean (SD) - 15 min (8.9 (1.70)), 30 min (18.9 
(4.60)) and 45 min (21.6 (4.39))  
TL (Min): Mean (SD)- 15 min (4.2 (2.04)), 30 
min (9.2 (3.76)) and 45 min (10.0 (4.47))) 
[57] Age 40.3±13.5 
Fifteen Type 1 diabetic patients, following multiple-dose 
insulin therapy and without significant micro- and macro-
vascular complications, were monitored from 5 to 22 days 
(average 12.5±4.6) in free-living conditions. 
10-fold cross- validation 
RMSE (mg/dl): Mean ± SD -  30 min (6.1±1.6) 
ESODnorm: Mean ± SD – 30 min (6.4±2.7) 






Fifteen type 1 diabetic patients, following multiple dose 
insulin therapy and without significant micro- and macro-
vascular complications, were monitored from 5 to 22 days 
(average 12.5 ± 4.6) in free-living conditions. 
10-fold cross- validation 
SVR—RF (RMSE (mg/dl): Mean ± standard – 30 min (5.7 ± 
1.5), 60 min (6.4 ± 2.1)), SVR—RRF (RMSE (mg/dl): Mean ± 






Fifteen type 1 diabetic patients, following multiple dose 
insulin therapy and without significant micro- and macro-
vascular complications, were monitored from 5 to 22 days 
(average 12.5 ± 4.6) in free-living conditions. 
10-fold cross- validation 
GP—RF (RMSE (mg/dl): Mean ± standard – 30 min (5.6 ± 1.7), 
60 min (6.3 ± 2.6)), GP—RRF (RMSE (mg/dl): Mean ± standard 
– 30 min (5.9 ± 1.6), 60 min (6.8 ± 2.9)) N/A 
[59] 
Age 43.5±13.4, 12 
female, 15 male 
The dataset includes 27 type 1 diabetic patients following 
multiple-dose insulin therapy and was collected in the 
framework of the EU research project METABO from the 
participating clinical partners. 
10-fold cross- validation RMSE (mg/dl): 15 min (6.60), 30 min (8.15), 60 min (9.25) and 
120 min (10.83) 
CG-EGA: 15 min (Zone A (99.26), Zone B 
(0.62)),30 min (Zone A (98.23), Zone B (1.39)), 
60 min (Zone A (97.59), Zone B (1.90)), and 120 
min (Zone A (96.43), Zone B (2.75)) 
[60]  & [61] & 
[62] & [63] 
N/A 
The data were collected from three type 1 diabetic patients 
over a period of 5, 11 and 13 days, respectively 
V-fold cross validation RMSE (mg/dl): 15 min (9.28), 30 min (15.59), 60 min (24.06) 
and 120 min (31.24) 
CG-EGA: the vast majority of points belong to 
the zones A and B 
N/A 
The data are collected from two type 1 diabetic patients 
over a period of 5 and 11 days, respectively. 
Random subsampling: For the evaluation of the proposed 
method, the dataset of each patient is randomly split into 
training and test sets. The training set consists of the 66% 
of the data, while the remaining data are used for testing. 
RMSE (mg/dl): 15 min (9.1), 30 min (14.8), 60 min (22.4) and 
120 min (28.2) 
N/A 
N/A 
Seven patients with type 1 diabetes with an average 
observation period of 10 days (range from 5 – 14 days) 
V-fold cross validation 
RMSE (mg/dl): Mean ± SD -  15 min (9.51 ± 2.39)), 30 min 
(16.02 ± 3.55)), 60 min (24.81± 4.74)) and 120 min (36.15 ± 
9.70)) 
CG-EGA: 15 min (Zone A (98.86 %), Zone B 
(1.08 %)),30 min (Zone A (92.54 %), Zone B 
(6.89 %)), 60 min (Zone A (80.02 %), Zone B 
(18.49 %)), and 120 min (Zone A (62.91 %), 
Zone B (33.78 %)) 
12 female, 15 male, 
age 19-72 (43.5±13.4) 
Data from 27 type 1 diabetics subject observation period 
of the study ranged from 5 to 22 days (average 13.42 ± 
3.69). 
Tenfold cross-validation 
RMSE (mg/dl): 15 min (5.21), 30 min (6.03), 60 min (7.14) and 
120 min (7.62) 
Mean Absolute Percentage Error: 15 min (2.06), 30 min (2.41), 
60 min (2.79), 120 min (3.02)  
CG-EGA: Accurate Reading - hypoglycaemia 
(15 min (96.76), 30 min (94.56), 60 min (92.16), 
120 min (90.05)), euglycemia (15 min (96.56), 
30 min (95.80), 60 min (94.93), 120 min 
(93.57)), hyperglycaemia (15 min(90.00), 30 min 
(89.28), 60 min (87.45), 120 min (84.85)) 
[64] 
N/A Clinical data from a group of 20 type 1 diabetes patients 
collected for a 30-day period 
Hold-out: A subset of the first 3204 (11 days and 3 h) and 
subsequent 1200 (4 days and 4 h) samples were selected 
as training and validation data, respectively. 
Overall Average RMS (mg/dl): One step prediction – 5.965 
N/A 
[65] 
N/A Data used here are 25sets of simulated blood glucose 
concentrations for 25 patients with various weights 
Hold-out: 70% of data is used for training, 15% for 
validation and 15% for testing  
NN with KF: MADavg% (60 min (29.10), 120 min (33.08)) N/A 
[66] 
9 males, 9 Females, 
Age 36.9±11.6 years 
Patients monitored for approximately two weeks Hold-out: The training data consisted of 6 days, while the 
validation set consisted of approximately 3 days. 
N/A N/A 
[67] & [68] 17 to 70 years of age 
Data collection time (days) –Training data (122 days), 
Evaluation set (111 days) 
Hold-out: Half of the dataset for each patient was used in 
training and identification of the parameters of the 
prediction models, and the other half was used for 
evaluation of the model’s performance.  
RMSE (mg/dl): Median (5th–95th Percentiles) - 15 (11.9 (7.7–
22.7)), 30 (18.9 (12.8–32.3)), and 45 min (26.1 (17.2–39.8)). 
TL (Min): Median (5th–95th Percentiles) – 15 
min (5.0 (0.5–10.0)), 30 min (10.0 (5.5–15.0)), 





average age 42.3 
(+/−11.07) 
Ten complete days of data for each patient Fold cross-validation N/A 
CG-EGA:  – 30 min (Zone A (91.5%), + Zone 





The population is 
characterized by 40% 
male and 60% female 
patients. The mean 
(SD) age is 42.9. 
Real - Sets of daily vectors collected from 5 patients of the 
Hospital Clinic Universities of Barcelona for a period of 6 
months.  
Hold-out: 3-days series as the in-sample data for fitting 
the model. The models have been tested with the 
remainder data (out-of-sample data). RMSE (mg/dl): 60 minutes (5.12) CG-EGA:  – 60 min (Zone A (61.98%), + Zone 
B (34.76%)) 
[71] N/A 
Virtual - Data obtained over 14 days for 100 virtual 
patients generated by the UVA/Padova T1D simulator N/A 
RMSE (mg/dl): 6-h prediction models (Nocturnal (11.80), 
Breakfast (22.09), Lunch (20.93), Dinner (29.00), Average-24 hr 
(20.96)) 
CG-EGA:  – 6-h prediction models (Zone A +B 
(Nocturnal (99.37), Breakfast (98.68), Lunch 
(98.02), Dinner (97.16), Average-24 hr (98.31)),  
[72] 
8 women and 9 men 
(28 to 64 years 
(average, 41.2±13.36) 
Seventeen type 1 diabetes patients were monitored for 
about 4 to 7 days (5.73±1.03 in average) in free-living 
conditions. 
N/A RMSE (mg/dl): Mean (SD)-30 min (2.37 (0.67)), 60 min (4.36 
(3.86)), 90 min (22.23 (24.13)) N/A 
[73] 23 years old 
Collected data are selected for five normal days in the 
patient, under medical supervision, with standard 
ingestion (three meals per day and some snacks) and 
without exercise events. 





Data recorded for over a period of 63 days,  which only 
had 463 blood glucose measurements is available in total 
which means that at 92% of the time steps, the blood 
glucose is unknown. 
Hold-out: The first 42 days of the data set for training the 
models (containing 312 measurements of the blood 
glucose) and the following 21 days for testing (containing 
151 blood glucose measurements)  
One step ahead prediction: achieved the best prediction 
performance with an explained variance of 45.7%. 
N/A 
[75] N/A 
Data from two type 1 diabetic patients who were 
monitored over a period of 5 and 11 days, respectively 
Leave-one-day out: the dataset of each patient is divided 
into two groups. The first group (i.e. test set) contains the 
data of 𝑖𝑡ℎ day, with i =1,…, k , where k is the total number 
of days and the second group contains the remaining data. 
RMSE (mg/dl): Physical Activity Input – Sensor Data (15 min 
(11.13), 30 min (18.84), 60 min (28.79), 120 min (46.7)), 
Exercise Modelling (15 min (10.84), 30 min (17.92), 60 min 
(27.5), 120 min (43.34)) 
CG-EGA: - 60 min (Zones A (72.075%) and B 
(25.22%)) 
[76] & [77] N/A 
In silico patients 48-h dataset  
Hold-out: The training dataset is formed by the 24-h 
records of five in silico patients. Testing dataset includes 
a different set of 24-h records for the same five in silico 
patients 
Average Mean and standard deviation of percentage average 
error: (14.12 (2.11)).  
CG-EGA: More than 95% of the data were found 
into Zone A 
[78] N/A Dataset containing 400 timestamps collected from 10 T1D 
patients, 40 points from each. 
Hold-out: Divide the datasets into 50/50% RMSE (mg/dl): 30 min (21.4), 60 min (38.0) N/A 
[79] 
Female patient, 23 
years old 
N/A Hold-out Mean value and standard deviation for the approximation error: 
0.0039mg/dl (0.0209mg/dl) N/A 
[28] 
7 male and 5 female 
(Age-19.83 ± 12.28) 
Twelve Patients were monitored for a ten day period. 
Hold-out: Data corresponding to the 60% of the monitored 
days were used for training purposes (model 
development), while the remaining 40% for testing 
(model evaluation) 
RMSE (mg/dl): Mean ± standard deviation (SD) - 30 min (14.10 
± 4.57), 60 min (23.19 ± 6.40) 
 
CG-EGA: Accurate readings – Hypoglycemia 
(30 min (81.06%), 60 min (63.22%)), Normal 
Glycaemia (30 min (92.18%), 60 min (91.71%)), 
Hyperglycemia (30 min (88.27%), 60 min 
(87.19%)) 
[80] N/A Twelve Patients were monitored for more than 14 days  
Hold-out: 70% of his recorded blood glucose data for the 
training step and used the remaining 30% of glycemic data 
to test the predictions 
Average RMSE (mg/dl): 15 min (9.44), 30 min (10.78), 45 min 
(11.82) and 60 min (12.95)  
N/A 
[81] N/A 
Twelve T1D patients (insulin-dependent diabetes) were 
using the Freestyle Libre System for 14 days. For each 
T1D patient, we have 1344 values of blood glucose. One 
more patient with three months long datasets. 
Hold-out: The blood glucose measurements were divided 
into two parts for each patient: 2/3 of data (896 samples) 
for training step (70%) and 1/3 (448 samples) for testing 
step. 
Average RMSE (mg/dl): 15 min (6.43), 30 min (7.45), 45 min 
(8.13) and 60 min (9.03) 
 
CG-EGA: the majority of points are located in 
the zone A which verifies a clinically satisfactory 
result, while a minor quantity of points are in the 
other zones (B and D). 
 
4.2. Evaluation and Analysis of the Literature 
As defined earlier, the included literature studies were evaluated based on the data characteristics and types of inputs 
(diabetes parameters) used to train the algorithm, the class of machine learning techniques adopted for the task, and 
the performance metrics used to assess the prediction performance. 
4.2.1. Data Characteristics and Input Parameters  
4.2.1.1. Input Parameters 
BG dynamics in people with diabetes is affected by various factors, such as the amount of insulin injection, the quantity 
of carbohydrate intake, the level and extent of physical activity, past readings of BG, stress (emotional feelings), any 
type of illness, alcohol consumption, smoking, menstruation, and others. An ideal BG predictor should incorporate all 
of these confounding variables for better estimation of the individual BG levels. According to the reviewed literature, 
BG, insulin, and diet comprise the most used group of parameters (29%), as shown in Figure 6. BG, insulin, diet, and 
physical activity make up the second most used group of parameters (25%). The use of only BG parameter ranked 
third (20%). The use of BG, insulin, diet, and physical activity, stress and, other groups of parameters ranked as the 
fourth most used (14%). The use of BG along with insulin and BG along with physical activity ranked equally as the 
fifth most used group of parameters (4%). The use of BG with diet and BG with insulin and physical activity ranked 




Figure 6: The type and number of input parameters used to train the models. 
4.2.1.2. Data Characteristics  
Data Sources 
Different types of data sources have been exploited in the reviewed articles for recording various parameters for the 
prediction of BG, ranging from continuous glucose monitoring systems, insulin pumps, physical activity trackers, 
simulators for BG dynamics, and diaries to record daily events related to diet and insulin injections. The reviewed 
studies have used different brands of CGM systems to collect continuous subcutaneous concentrations of BG in the 
range of different minuets (i.e., 1–15 minutes). The most used CGM system is Guardian Real Time (MinMed, CGM), 
as shown in Table 3 below. The second most used CGM system is Dexcom SEVEN PLUS (CGM) (13.5%) and Abbott 
Freestyle (CGM) (13.5%). The third most used CGM system is FreeStyle Libre CGM and other unspecified brands 
(5.5%).  
Table 3: Brands of CGM devices used in the studies. 
CGM Count  Percentage  
Dexcom SEVEN PLUS (CGM) 5 13.5% 
Guardian Real Time (MinMed, CGM) 23 62% 
Abbott Freestyle (CGM) 5 13.5% 
FreeStyle Libre CGM 2 5.5% 
Other CGMs 2 5.5% 
 
Regarding insulin pumps, different brands have been used. For example, the Paradigm Veo – 754 insulin pump is the 
most used brand (56%), as shown in Table 4 below. The second most used brands are Mylife Omnipod insulin pumps 
and AccuChek insulin pump (11%). Other non-specified brands of insulin pumps have also been used (22%). 
 
Table 4: Brands of insulin pumps used in the studies. 
Insulin Pump Count  Percentage  
Paradigm Veo - 754 insulin pumps 5 56% 
Mylife Omnipod insulin pumps 1 11% 
AccuChek insulin pump 1 11% 
Other Insulin Pumps 2 22% 
 
Physical activity is one of the key factors having a significant effect on BG dynamics. To this end, some studies have 
tried to measure the amount of physical activity using wearable fitness trackers, such as SenseWear Armband (89%), 
as shown in Table 5 below. It collects data using five sensors: heat flux, skin temperature, near body temperature, 
galvanic skin response, and a two-axis accelerometer. Some other studies also have used Fitbit Charge HR devices 
(11%) to record the amount and duration of physical activities.  
Table 5: Brands of physical activity trackers used in the studies. 












BG, Insulin & Diet
BG & Physical Activity
BG, Insulin & Physical Activity
BG, Insulin, Diet & Physical Activity
BG, Diet, Insulin, Physical Activity, Stress & Others
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Fitbit Charge HR™ devices 1 11% 
SenseWear Armband 8 89% 
 
Some studies have used either electronic or paper diary to record daily events such as meal and insulin injection. Most 
of the studies used a paper diary (50%), where the patient is expected to record his/her daily carbohydrate intake and 
insulin injection, as shown in Table 6 below. Some other studies have used a smartphone diary (22%) and other 
unspecified forms of diaries (28%).  
Table 6: Types of diary used in the studies. 
Diary Count  Percentage  
Paper Diary 9 50% 
Smartphone Diary 4 22% 
Others  5 28% 
 
Some other studies have used a virtual patient’s (in silico patient) data simulated from different tpes of BG simulator 
software. Among them, AIDA is the most used (50%), followed by UVA/Padova (30%), as shown in Table 7 below. 
The third most used software types are Glucosim and other non-specified simulators (10%). 
Table 7: Types of blood glucose simulator used in the studies 
Simulator Count  Percentage  
UVA/Padova 3 30% 
AIDA 5 50% 
Glucosim 1 10% 
Other simulators  1 10% 
Data Preprocessing  
It is obvious that all machine learning algorithms tend to learn much quicker and effectively when the inputs and 
targets are preprocessed before training the network. For example, normalizing the input between 0 and 1 helps to 
keep the network weights from becoming too large [82]. In this regard, various data preprocessing techniques have 
been used in the reviewed articles, such as a smoothing using low pass filter [18], normalization [22], scaling [23], the 
interpolation of missing values [44, 78], and the differentiation of BG values. Others, featuring extraction and 
reduction [29, 69], include using the fuzzy approximation of food and exercise data [49], ranking candidate feature 
sets using random forest and RReliefF algorithms [58], and noise filtering using a Kalman filter [44, 65].   
4.2.2. Class of machine learning 
Various classes of machine learning techniques have been used in general dynamic system modeling, regression, and 
prediction services. However, for BG prediction, feed-forward neural networks are the most used techniques (20%), 
as shown in Figure 7. The hybridization of the physiology-based model and machine learning techniques is the second 
most used approach (19%). Recurrent neural networks in various forms ranked as the third most used technique (18%). 
Support vector machines (SVMs) ranked as the fourth most used technique (11%). Genetic programming techniques, 
most notably grammatical evolution, ranked as the fifth most used technique (6%). Autoregressive neural networks 
and neuro-fuzzy networks are the sixth most used techniques (5%). Self-organizing maps (SOMs) ranked seventh 
(4%). Extreme learning machines, kernel functions, Gaussian processes, genetic algorithms, and random forests 




Figure 7: Classes of machine learning techniques used in the modeling of blood glucose prediction. 
4.2.3. Performance Metrics  
Performance metrics are necessary steps that should be carefully chosen based on the developed model under 
consideration. Various performance metrics are used to assess the predictive power of the developed model. However, 
choosing the appropriate metrics depends on the type of application the model is intended to use. Based on the 
reviewed articles, the performance metrics used to assess the predictive performance of the final model can be 
categorized into two groups: mathematical evaluation criteria (empirical accuracy) and clinical evaluation criteria 
(clinical accuracy). The mathematical evaluation criteria (empirical accuracy) are simply used to evaluate the 
numerical accuracy without giving due consideration to the clinical significance. This group of metrics includes root 
mean square error, correlation coefficient, FIT, normalized prediction error (NPE), and geometric mean. The clinical 
evaluation criteria (clinical accuracy), however, give due consideration to their significance in terms of clinical 
usability and include error grid analysis, average time gain, mean absolute relative difference, expert comparison, and 
J index. Generally, the most popular performance metric is root mean square error (36%), followed by Clarke error 
grid analysis (19%), as shown in Figure 8. The third most popular metric is correlation coefficient (12%), followed 
by temporal gain (8%). The fifth most popular metric is mean absolute error and mean absolute difference percent 
(5%). The sixth most used metrics are mean absolute relative difference, energy of the second order difference, and 
mean squared error (3%). The seventh most used metrics are normalized prediction error, expert reference, and J index 
(2%). 
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4.2.4. Prediction horizon (PH)    
Prediction horizon (PH) is the lead time in which the model is able to forecast BG levels in the future. A wide range 
of prediction horizons have been reported from 15 minutes up to 2 hours and more. A satisfactory accuracy level is 
achieved for 15- and 30-minute PH with subsequent degradation afterwards. It is obvious that due to the limited 
number of available confounding factors in the data used to train the model, it is natural to expect degradation in 
prediction power as the prediction horizon increases. However, an increase in temporal gain (TG) enhances the clinical 
usability of the prediction services by prolonging the time necessary to take the required action during a critical 
situation but at the expense of clinical accuracy. Therefore, it is necessary to compromise on these complementary 
issues to achieve a reasonable predictive power and prediction horizon.  
4.3. Strategies to Integrate the Effect of Diet, Physical Activity, Stress, and Infections  
BG is affected by many factors, and its dynamics resemble a complex nonlinear process. However, the prominent 
parameters include the insulin medication, physical activity (exercise), the type of diet, the illness, and stress. A 
successful BG predictor is at least expected to integrate the continuous effect of these factors on BG dynamics. In this 
regard, integrating these effects has been attempted, however, with certain limitations. The proposed approaches to 
integrating the effects of diet, physical activity (exercise), illness, and stress into the BG predictor are described in the 
following section. 
4.3.1. Proposed Approach to integrating the effect of diet (meals) 
Diet has a tremendous effect on the level of BG. A certain diet could consist of various nutritional contents, such as 
carbohydrates, proteins, fiber, fat, and others. For people with diabetes, carbohydrates could be regarded as the most 
widely adopted means of meals planning. However, many factors affect the impact of carbohydrates on BG levels, 
(e.g., the type of carbohydrate and glycemic index). The carbohydrate glycemic index determines the rate at which it 
is digested, absorbed, and metabolized, thereby defining the rate at which it affects BG levels. According to the 
reviewed literature. as shown in Table 8 below, diet information, such as the number and time of meals, is mostly 
estimated in carbohydrate (grams) and manually recorded by patients using either a paper diary or an electronic diary. 
However, several researchers, including Zecchin et al. [25], have attempted to automate the procedure of recording 
diet information. Zecchin and colleagues [25] exploited information regarding the amount of ingested carbohydrates 
using a meal picture taken by a standard mobile phone. Generally, the integrations to the machine learning models are 
performed using directly the carbohydrates (grams), calculating the calorific values of meals, or relying on a 
























Table 8: Proposed approach to integrating estimation of food intake (Real subjects) 
 
As a substitute for actual meal data, simulated meal information has been generated and used to develop and test the 
predictor algorithm, as shown in Table 9 below. This simulation considers a meal scenario representing the major 
meals of breakfast, lunch, dinner, and snacks, taking into account the different amounts of carbohydrate and meal 
time. The simulation is carried out by either varying the amount of carbohydrates for each meal or by varying the time 
References Proposed Approach 
[19] Carbohydrate consumption estimated in grams (g). 
[20] Carbohydrate consumption estimated in grams (g). 
[25] & [15] Patients used a mobile phone to take a meal picture, which was used to extract information about ingested carbohydrate (g). A physiological model was 
exploited to suitably preprocess information regarding the timing and amount of ingested carbohydrate within the meal.  
[28] Carbohydrate consumption estimated in grams (g). Compartmental models (CMs) was used to estimate glucose absorption into the blood from the gut. 
[29] Patients self-recorded information regarding the amount of  ingested carbohydrates (in grams). 
[33] & [34] Patients received standardized meals (breakfast, lunch and dinner), where the amount of carbohydrates included in each meal was about 40 (45 in DAQ), 
70 and 70 g, respectively. 
[38] & [39] A diet vector was formed containing total carbohydrates (g) and time of meal. A chart devised by the University of Glasgow Dietetics’ Department was 
used to calculate and subdivide the calorific values of meals into energy, total carbohydrate, sugar carbohydrate, protein, fat, fiber and sodium.  
[42] Carbohydrate consumption estimated in grams (g). 
[43] Carbohydrate consumption measured in grams (g). 
[45] Pocket PC-based electronic diary was used to record nutritional content (patient self-recorded information). 
[46] & [47] An electronic diary documenting carbohydrate intake (patient self-recorded information) was used to record meal information. 
[49] Four types of food that correspond to the description of food units (compendium of food measures with associated carbohydrate composition) provided by 
the Canadian Diabetes Association were used. A fuzzy approximation was used to estimate food content (simple sugars (in grams), fruits (in grams), milk 
products (in grams), starch (in grams)). 
[50] Amount of carbohydrate ingested was estimated and a compartmental model was used to capture its effect on BG dynamics.  
([51] The effect of carbohydrate intake on BG absorption from the gut was estimated using compartmental model. 
[53] Patient self-recorded information - Patient dairy was used to record carbohydrates (in grams). 
[56] Food intake considered in terms of carbohydrates ingested.  
[57] Patient self-recorded information – a paper diary was used to record food intake information (type of food, serving sizes and time). The amount of 
carbohydrate in each meal was post-analyzed by a dietician. A compartmental model was used to estimate rate of appearance (Ra) of meal-derived glucose 
into plasma within a time interval.  
[58] Patient self-recorded information – a paper diary was used to record information on food intake (type of food, serving sizes and time). The amount of 
carbohydrate in each meal was post-analyzed by a dietician. A compartmental model was used to estimate rate of appearance (Ra) of meal-derived glucose 
into plasma within a time interval. 
[59] 
 
Patient self-recorded information – a paper diary was used to record daily food intake information (type, amount and time). The specific amount of 
carbohydrate in each meal was post-analyzed by a dietician. Lehmann’s [83] compartmental model was used to estimate rate of appearance of exogenous 
(meal-derived) glucose in plasma (𝑅𝑎), in which the rate of gastric emptying is a function of meal carbohydrate content. 
[60]  & [61] & 
[62] & [63] 
Patient self-recorded information – a paper diary was used to record information on food intake (type of food, serving sizes and time).  A dietician analyzed 
the food composition (i.e. calories, carbohydrates, fat etc.) and a compartmental model was used to estimate ingestion and absorption of carbohydrates 
(Meal Model). 
[64] The software described in Percival [84] was used to calculate the carbohydrate (CHO) intake of each patient (g CHO). 
[66] 
 
Patient self-recorded information – Participants used a diary to record a detailed food intake in terms of carbohydrate ingested. Lehmann’s compartmental 
model [83] was used to estimate the amount of glucose entering the bloodstream via the guts.   
[69] The amount of carbohydrate was estimated by the patients. A Gaussian process enhanced with compartmental model was used to create smoothed time 
series of the original carbohydrate and insulin records. 
[70]  The carbohydrate intake was estimated by patients and measured in grams (g). 
[73] Carbohydrate consumption estimated in grams (g). Lehmann’s compartmental model [83] was employed to approximate continuous glucose absorption by 
gut, after carbohydrate oral consumption. 
[74] The amounts and times of food intake (fast, intermediate, and slow-carbohydrates) and compartmental model was used to estimate its effects on BG 
dynamics. 
[75] Patients manually notified food ingested (serving sizes, and time of each meal or snack), and insulin injections (type, dose and time). A dietician analyzed 
the food composition (calories, carbohydrates, fat etc.). Lehmann’s [83] compartmental model was used to describe time course of glucose appearance in 
plasma after meal intake.  The amount of glucose in the gut, qgut, after ingestion of a meal containing D grams of glucose-equivalent carbohydrates was 
defined. 
[76] The amount of carbohydrates units ingested. 
[78] The amount of carbohydrates units ingested. A physiological model from duke’s PhD thesis [85] was used to describe the BG dynamics upon food intake  
[79] The patients provide amount of ingested carbohydrates (in grams) and course of time. Lehmann’s compartmental model [83] was employed to approximate 
glucose absorption by intestine after oral ingestion. 
[28] 
 
Meal information (amount of carbohydrates ingested and time of meal). A compartmental model was used to estimate glucose absorption from the gut. The 
model of glucose intestinal absorption was represented by a three-compartment nonlinear model - the stomach (solid and liquid phases) and intestine. The 
model assumed a constant rate of intestinal absorption but described gastric emptying rate to be dependent on total amount of nutrient in the stomach.  
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of meals and sometimes considering both. The variations are generated based on a preset range of values to randomly 
select from or using a random variable drawn from a uniform distribution.  
Table 9: Proposed approach to integrating estimation of food intake (Virtual subjects) 
 
4.3.2. Proposed approach to integrating the effect of physical activity (exercise) 
Physical activity (exercise) has a significant effect on BG dynamics [86]. However, the effect of physical activity 
(exercise) on BG varies considerably based on many factors, such as the type of activity, amount and intensity of 
activity, and duration. According to the reviewed literature, as shown in Table 10 below, physical activity information 
has been recorded either manually using paper and electronic diaries or automatically using wearables, such as 
SenseWear Armband and Fitbit Charge HR devices. A wide variety of physical activity (exercise) information has 
been considered, such as the degree of activity, the sum of energy expenditure during a range of time intervals, standard 
tables for caloric use during exercise, the metabolic equivalent of task (MET), the heat flux (hf), and skin temperature 
(S𝑡) variables. The integration to the machine learning model is carried out by relying on four main approaches: using 
the scale and time of activity, directly feeding the recorded time and duration of the activity, directly feeding the data 

























References Proposed Approach 
[22] 
 
A scenario representing the major meals were simulated: breakfast, lunch, dinner, and snack. The daily variations in quantity and timing regarding each 
meal was handled through a randomized approach: each kind of meal was assigned a range of possible quantities of grams of CHO and timings. For 
each day and meal, the approximate number of grams of CHO and the timing was chosen randomly from the respective ranges. 
[23] & [24] A simulation scenario consisted of the three major meals per day in a range of time intervals, Breakfast (45 + u g), Lunch (75 + u g) and dinner (85 + 
u g), where u was defined as is a random variable drawn from a uniform distribution. 
[33] A simulation scenario consisted of the three major meals per day with a range of amount of carbohydrates (g) and fixed timing.  A random amount of 
carbohydrate (g) was selected from the specified range: Breakfast (08:00, 45±5 g), Lunch (12:30, 70±10 g), Dinner (19:00, 80±10 g). 
[40]  A simulation scenario consisted of 2 meals (carbohydrate (in grams)) per day and random timings 13:30 (Meal 1) and 19:00 (Meal 2) ±30 minutes. 
[41]  A simulation scenario consisted of a meal measured in carbohydrate intakes (in grams). 
[71] A simulation scenario consisted of the major three meals (carbohydrate (in grams)) per day with average intakes: breakfast (50 g), lunch (60 g), dinner 
(63.5 g), and a coefficient of variation (CV) of 20%, sampled using a Gaussian distribution. The information of carbohydrate intake also includes 20-
g hypo treatments that were generated every 20 min when the glucose concentration fell below 60 mg/dl, as indicated by the SMBG measurements. 




The simulation scenario was carried out by varying the parameters of the simulator to account for realistic situations, varying carbohydrates and/or 





Table 10: Proposed approach to integrating physical activity/exercise (Real subjects) 
 
4.3.3. Proposed Approach to integrating the effect of stress and Infections 
Emotional stress or physiological stress caused by illness and infections could affect BG homeostasis due to hormonal 
changes in the body. In this regard, recent findings have indicated that emotional stress and infection have a strong 
impact on glycemic control, resulting in elevated BG (hyperglycemia) [89-92]. Only a few researchers have tried to 
integrate the effect of stress and illness, as shown in Table 11 below, using a scale to indicate the level of the stress 
References Proposed Approach 
[19] Patient self-recorded exercise information using a scale from 1 to 5 was used to express the degree of physical exercise, where 1 means at rest and 5 
means doing heavy physical exercise.   
[26] Energy expenditure as a result of daily physical activity or exercise events was recorded with a resolution time of 1 min using SenseWear Armband. The 
integration was carried out considering the sum of energy expenditure during a time period [t—150 min, t—120 min], which takes into account physical 
activity during the latest 30 min with a lag time equal to 120 min. 
[27] Energy expenditure as a result of daily physical activity or exercise events was recorded with a resolution time of 1 min using SenseWear Armband. 
[29] Patient self-recorded exercise information, where the integration was carried out using a scale of 1 to 5 to describe the intensity and duration. In this 
regard, a value of 1 indicates no exercise at all, and a value of 5 means heavy physical exercise based on interval of time. 
[38] & [39] Patient self-recorded physical exercise based on duration (mins), mobility (0-3), strength (0-3), endurance (0-3) and time of exercise (absolute), where 
mobility, strength, and endurance are expressed using a scale from 0 to 3. An exercise vector containing all these parameters was used to create a serious 
of events, which was fed to the model.  
[42] Patient self-recorded exercise information using a scale from 1 to 4 was used to express the magnitude and duration, where 1 means doing nothing and 
4 signifies heavy exercise. 
[45] Patient self-recorded exercise information using a Pocket PC-based electronic diary to record lifestyle/activities. 
[46] & [47] Patient self-recorded exercise information using an electronic diary to record lifestyle (activities and events) 
[49] The intensity of physical exercise was considered based on three possible levels (moderate (baseball, walking), hard (hockey, basketball), strenuous 
(jogging, rowing)) and the patient was excepted to perform a fuzzy approximation based on these three levels.  
[53] Standard tables for caloric use was used to properly use the physical exercise data from the patients.  
[56] Physical activity data was recorded using Fitbit Charge HR devices 
[57] SenseWear Armband was used to compute and record energy expenditure. The integration was carried out considering the energy expenditure calculated 
cumulatively every 10 min over the last three hours based on the instantaneous (i.e. per minute) energy expenditure estimated by the SenseWear 
Armband. 
[58] SenseWear Armband was used to compute and record energy expenditure every 1 min. The integration was carried out considering the energy 
expenditure calculated cumulatively every 10 min over the last three hours based on the instantaneous (i.e. per minute) energy expenditure estimated by 
the SenseWear Armband.  
[59] SenseWear Armband was used to compute and record energy expenditure every 1 min. The integration was carried out based on cumulative energy 
expenditure (SEE) to consider the short-term effects of physical activities and exercise on glucose variability by expressing the energy expenditure over 
the last 3 hrs.in the form of a vector calculated cumulatively every 10 min. 
[60]  & [61] & 
[62] & [63] 
SenseWear Armband was used to compute and record energy expenditure every 1 min using the five sensors: heat flux, skin temperature, near body 
temperature, galvanic skin response and a two-axis accelerometer. The integration was carried out in two different approaches: using the SensWear 
armband data directly or using the compartmental models to describe the effect of physical activities on glucose-insulin metabolism (Exercise Model): 
 The first approach utilizes, the Metabolic Equivalent of Task (MET), heat flux (hf) and skin temperature (S𝑡) variables, as recorded by the 
SenseWear armband, as inputs to the model.  
 The second approach utilizes the output (𝐺𝑒𝑥𝑒𝑟, 𝐼𝑒)from the exercise compartmental models. 
[64] The amount and degree of physical exercise was computed based on an assumption of three level code: low (50–150 cal/30 min), moderate (150–200 
cal/30 min) and strong (>200 cal/30 min). The integration was carried out using a mathematical interpolation function that considers the variation in 
physical exercise on a range of 0–2 (Exc. level: 0 (low), 1 (moderate), 2 (strong)), and the rates of carbohydrate and calorie consumption as described 
in literatures [86, 87].  
[66] SenseWear armband was used to compute and record physical activity using the 5 different sensors; transversal acceleration (measure of movement), 
longitudinal acceleration (measure of movement), heat flux (average heat dissipated or absorbed by the arm), galvanic skin response (electrical 
conductivity between two points on the arm), and skin and near-body temperature. A proprietary algorithm was employed used to estimate the physical 
activity energy expenditure by combining these different physiological signals. 
[88] The times and durations of physical exercise (regular, or intense) 
[75] 
 
SenseWear armband was used to compute and record physical activity using the 5 different sensors; heat flux, skin temperature, near body temperature, 
galvanic skin response and a two-axis accelerometer. The integration was carried out using two different approaches to investigate the dynamic effect 
of exercise on glucose variation:  
 In the first approach, the Metabolic Equivalent of Task (MET), the heat flux (hf) and the skin temperature (S𝑡) variables, as recorded by the 
SenseWear armband, are used directly as inputs to the model.  
 However, in the second approach the output from the exercise compartmental models was used.  
The study reveals an important observation: using directly the real sensor data or the output from the exercise compartmental models, produce a relatively 
small difference in performance (RMSE).  
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and binary values to indicate the absence and presence of illness. However, these studies have limitations in terms of 
quantifying the approximate effect of stress and illness in response to BG levels.  
Table 11: Proposal to integrating presence of stress and illness (Real subjects) 
 
References Proposed Approach 
Stress Illness and pregnancy 
[19] A scale of one up to five was used to define the presence and 
magnitude of stress: one means relaxing and five means heavy stress. 
N/A 
[29] Patient self-recorded stress information on a scale of one to five based 
on interval of time: value of one indicates very relaxing, and the value 
of five means heavy stress 
N/A 
[38] & [39] 
A scale of zero to one was used to indicate the absence and presence of 
a stress: zero indicates absence and one indicates presence of stress. 
A scale of zero to  one is used to indicate the absence and 
presence of illness, surgery, and pregnancy: zero indicates 
absence and  one indicates presence of stress. 
 
4.4. A Comparative Assessment of Prediction Performances  
The predictive performance of a BG predictor is affected by many technical factors and design choices, apart from the 
factors that affect BG dynamics, such as the type of machine learning, data size, prediction horizon (PH) and validation 
approaches considered, and others. We have used the most popular performance metrics, RMSE, to compare the 
reported performance levels by different researchers. According to the reviewed literature, different classes of machine 
learning and types of validation approaches have been tested and confirmed as being up to the task, as shown in Table 
12 below. Please note that these performances are achieved based on real subject data. 
Table 12: Reported predictive performance (RMSE) considering the class of machine learning employed, validation 
strategies and prediction horizon considered (Real Subjects). 
Reference Machine Learning  Validation  RMSE (mg/dl)( Mean/ Mean ± SD) 
15 min 30 min 45 min 60 min 120 min 
[17] Recurrent Neural Network (RNN) Random subsampling 2.52 7.56 15.12 23.76  
[18] Feed Forward Neural Network (FFNN) Random subsampling 2.70 7.56 14.94   
[23] & [24] Hybrid (Feed Forward Neural Network Plus Linear 
Prediction Algorithm) along with Physiological Model 
k-fold cross-validation 
 9.4±1.5    
[25] & [15] Hybrid (Jump Neural Network along with Physiological 
Model) 
k-fold cross-validation 
 16.6 ± 3.1    
[26] Feed Forward Neural Network (FFNN) 10-fold cross-validation  13.31 ± 4.47  22.66 ± 6.86 37.62 ± 11.79 
Self-organizing map (SOM)  11.42 ± 2.33  19.58 ± 3.80 31.00 ± 6.07 
A Neuro-Fuzzy Network with Wavelets as Activation 
Functions (WFNN) 
 15.22 ± 2.17  24.66 ± 3.39 39.59 ± 5.03 
[28] Hybrid (Compartmental model (MM)) and Self-
Organizing Map (SOM) - Vector Quantization Method) 
Hold-out 
 14.10 ± 4.57  23.19 ± 6.40  
[31] Ensemble Approach Hybrid-Fusion (AR, Extreme 
Learning Machine, and Support Vector Regression- 
Kernel Function (Gaussian)) 
Hold-out 
 19.0 ± 0.3    
[36] & [37] Feature based Feed-Forward Neural Network (FFNN) Random subsampling  10.00 15.00 20.00  
[43] Hybrid (Generic Physiological Model & Support Vector 
Regression- Gaussian kernel) 
Random subsampling 
 22.6  35.8  
[44] Feed-Forward Neural Network model using Guardian 
CGM 
Hold-out 
9.74±2.71 17.45±5.44 25.08±8.73   
Feed-Forward Neural Network Model using FreeStyle 
Navigator CGM 
10.38±3.15 19.51±5.53 29.07±6.77   
[56] Hybrid-Fused (ARX and Elman simple Recurrent Neural 
Network) for prediction and Extreme Learning Machine 
for correction 
Hold-out 
8.9 ±1.70 18.9± 4.60 21.6 ± 4.39   
[57] Single hidden layer Feedforward Neural Networks - 
(kernel RLS, Gaussian kernel) - Extreme Learning 
Machine  
10-fold cross- validation 
 6.1±1.6    
[58] Support Vector Regression (SVR—RF) 10-fold cross- validation  5.7 ± 1.5  6.4 ± 2.1  
Support Vector Regression (SVR—RRF)  5.9 ± 1.4  6.8 ± 2.0  
[58] Gaussian Processes (GP—RF) 10-fold cross- validation  5.6 ± 1.7  6.3 ± 2.6  
Gaussian Processes (GP—RRF)  5.9 ± 1.6  6.8 ± 2.9  
[59] Hybrid- (Random Forests Regression technique & 
Compartmental Model) 
10-fold cross- validation 
6.60 8.15  9.25 10.83 
[60]  & [61] & 
[62] & [63] 
Hybrid- (Support Vector Machines- Linear kernel and 
Compartmental Model) 
v-fold cross validation 
9.28 15.59  24.06 31.24 
Hybrid- (Support Vector Machines- Linear kernel and 
Compartmental Model) 
Random subsampling 
9.1 14.8  22.4 28.2 
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Hybrid- (Support Vector Machines- Linear kernel and 
Compartmental Model) 
v-fold cross validation 
9.51 ± 2.39 16.02 ± 3.55  24.81± 4.74 36.15 ± 9.70 
Hybrid- (Support Vector Machines- Linear kernel and 
Compartmental Model) 
10-fold cross-validation 
5.21 6.03  7.14 7.62 
[67] & [68] Hybrid-Fused (Autoregressive Model with output 
correction – cARX, & Recurrent Neural Network – 
RNN)-Data fusion (Genetic Algorithms (GA), & Genetic 
Programming (GP)) 
Hold-out 
11.9 18.9 26.1   
[70] & [71]  Hybrid (Genetic Programming - Grammatical Evolution 
& Physiological model) 
Hold-out 
   5.12  
[75] Hybrid-(Compartmental model & Support Vector 
Regression- linear kernel) using Physical Activity – 
Sensor Data as Input 
Leave-one-day out 
11.13 18.84  28.79 46.7 
Hybrid-(Compartmental model & Support Vector 
Regression- linear kernel) using Exercise Modelling 
10.84 17.92  27.5 43.34 
[78] Recurrent Neural Network (RNN) Hold-out  21.4  38.0  
[28] Hybrid- (Compartmental Models (CMs) and a Self-
Organizing Map (SOM) - Vector Quantization Method) 
Hold-out 
 14.10 ± 4.57  23.19 ± 6.40  
[80] Support Vector Regression (SVR) based on Differential 
Evolution (DE) Algorithms 
Hold-out 
9.44 10.78 11.82 12.95  
[81] Feed Forward Artificial Neural Networks (FFNN) Hold-out 6.43 7.45 8.13 9.03  
 
4.4.1. Validation Strategies 
The purpose of training any machine is to be able to get better predictions of the testing values by enabling the machine 
to generalize from the training examples of all possible inputs. However, the complementary issues of overfitting and 
under training are challenging, given the large degree of variability in most machine learning algorithms. The training 
algorithm should be able to avoid overfitting with enough generalization power by relying on a third set of datasets 
known as validation sets [82]. The main purpose of cross-validation is to evaluate the generalization power of the 
algorithm and to compare and find the best algorithm among a set of multiple algorithms [93]. There should be enough 
data size in the three datasets (training, testing, and validation sets) so that the machine does not overfit or undertrain. 
The proportion of splitting these datasets into these three groups is up to the expert and is dependent on the model 
selection [82]. Various strategies have been proposed for cross-validation, including re-substitution validation, hold-
out validation, k-fold cross-validation, leave one out cross-validation, and repeated k-fold cross-validation [93]. In 
this regard, the most popular strategies used in the reviewed articles are various forms of the k-fold cross-validation 
[25, 26], and hold-out [18, 19]. K-fold cross-validation strategy involves splitting the datasets into randomly 
partitioned k equal subsets and using one set as a validation sets and the rest for training, repeating the same process 
for all the different subsets [82]. However, hold-out involves portioning the datasets into non-overlapping subsets, 
where the first subset is entirely used for training and the rest for testing [93]. In this regard, among the most widely 
used validation approaches (k-fold cross-validation, random sampling, and hold-out), k-fold cross-validation achieves 
the best performance for all prediction horizons except for a prediction horizon of 15 min, where random subsampling 




Figure 9: A comparative assessment of the predictive performance based on the adopted validation strategies and 
prediction horizon (PH) using data of real subjects. The average RMSE for each prediction horizon is computed by 
averaging the performance levels reported by different authors, taking into account the proposed validation 
approaches. 
5. Discussion 
5.1. Principal findings  
Recently, machine learning has received wider attentions for modeling and the prediction of BG dynamics. Regardless 
of its popularity, no recent reviewers have analyzed and reflected on the current development. As far as our knowledge 
is concerned, no review has focused mainly on modeling and the prediction of BG dynamics using machine learning 
techniques. Therefore, the purpose of this review is to assess and analyse the state-of-the-art machine learning 
applications in BG prediction pertinent to the controller of an artificial pancreas (a closed-loop system), modeling of 
a personalized profile, personalized decision support systems, and BG alarm event applications. It serves as a compact 
guide regarding modeling options and strategies of machine learning applications and the hybrid system in type 1 
diabetes. Some recent reviews have been conducted on diabetes in general and on BG prediction in particular [11-13]. 
For instance, Oviedo et al. [12] recently conducted a methodological review on BG prediction, focusing mainly on a 
closed-loop system (an artificial pancreas), which assessed a variety of approaches, including physiological models, 
data-driven models, and hybrid approaches. Kavakiotis et al. [11] also performed a systematic review of the 
applications of machine learning and data mining techniques in diabetes research in the context of diabetes prediction 
and diagnosis, diabetes complications, genetic background and environment, and healthcare and management. 
BG dynamics are affected by numerous factors, such as the history of BG values, the insulin medication, physical 
activity, and dietary intake. Moreover, they are also affected by other factors, such as an individual’s body mass index, 
stress level, amount of sleeping time, presence of illness, some medications, smoking habit, periods (menstruation), 
alcoholism, allergies, and altitude. In principle, a successful BG predictor is expected to incorporate as much 
information as possible to effectively track and predict BG levels. However, due to the complexity of BG dynamics, 
it remains difficult to achieve an accurate prediction in every circumstance. Most of the available BG prediction 
algorithms have their own limitations, working better in some specific circumstances. The reported BG prediction 
algorithms have explored various classes of machine learning, input parameters, and training algorithms. Most of these 
studies have neglected the effect of physical activity on BG dynamics, and only a few studies have considered the 
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algorithms can be categorized under different scenarios, such as real time (online) versus offline, the age group 
(children, adult, and old), BG regions (hypo/eu/hyperglycemia events), the time of day (diurnal vs. nocturnal), 
generalizability (generic vs. specific), free-living versus non-free-living conditions, and the evaluation approach (in 
vivo vs in silico). Accordingly, most researchers have considered separate age groups, which are typically related with 
the dynamics and active lifestyles adopted by each group. Few attempts have been made to develop real-time 
algorithms that perform under free-living conditions. Moreover, most of the reported algorithms perform better in 
either of these BG regions (hypo/eu/hyperglycemia events). Furthermore, most of the algorithms rely on in silico 
evaluations, which further put the clinical significance in question. Also, the lack of a well-defined approach to 
estimate carbohydrate intake is an issue; it is mainly done manually by the individual users and is prone to an error 
that can severely affect the predictive performance. The lack of a universal approach to estimate and quantify the 
approximate effect of physical activities, stress, and infection incidence on the BG level is another challenge. For 
instance, regarding physical activity integration, a wide variety of approaches have been proposed, such as using a 
scale and level code to quantify the degree and duration of physical activity, the sum of energy expenditures during 
an interval of time, physical activity, caloric use based on standard table, MET, exercise compartmental models, a 
proprietary algorithm to estimate the physical activity energy expenditure by combining different physiological signals 
such as transversal acceleration (a measure of movement), heat flux (the average heat dissipated or absorbed by the 
arm), longitudinal acceleration (measure of movement), skin and near-body temperature, and galvanic skin response 
(electrical conductivity between two points on the arm). It seems that almost all the studies have followed quite 
different approaches, and this poses a challenge in regarding one’s approach as universal. In addition, also few studies 
have been done regarding model portability that can capture the inter- and intra-variation among the patients. It also 
seems that the effect of time lags between the CGM reading and the actual BG levels is not well covered. Generally, 
the review indicates the lack of a one-fits-all algorithm that performs better under totally free-living conditions.  
Any successful BG prediction algorithm should at least consider both the patient’s controllable (BG, insulin, diet, 
physical activity, and others) and uncontrollable parameters (stress, infections, medications, and others). Moreover, it 
is also necessary to consider any relevant contextual information, such as intra- and inter-variability among the 
patient’s changes in lifestyles, the time of day (diurnal vs nocturnal) and others. Future scholars need to reflect on a 
longer prediction horizon (giving more response time) with reasonable clinical accuracy, approaches to improve time 
lags from the CGM, real-time capability under free living conditions, and a thorough validation using real patients 
(clinical trials) with ample subjects over a longer period of time. Moreover, the predictor should give proper weights 
and penalties for errors in hypoglycemia, euglycemia, and hyperglycemia regions. It is also necessary to consider a 
proper way to estimate the amount and effect of dietary consumption and physical activity during integration with the 
machine learning model. Stress and infections have a prominent effect on BG dynamics, which could in turn affect 
the predictor performances. To this end, it is necessary to test and assess the effects of a change in either lifestyle or 
physiology (infections) on the predictor performance using subjects who are monitored within different periods. 
Furthermore, the effect of different CGM devices on the quantitative performance of the prediction algorithms should 
be explored along with the associated time lag. 
5.2. Summary of Existing Efforts (Machine Learning Techniques) 
5.2.1. Artificial Neural Network (ANN) 
An artificial neural network (ANN) is a computational model consisting of various processing elements known as 
neurons and a scaled connection between them called weights [94]. Various forms of artificial neural networks are 
used, but the network topology could be generally categorized as feed-forward networks (SLP, MLP, and radial basis 
function) and recurrent/feedback networks (Elman net, Kohonen’s SOM, and Hopfield Networks). The feed- forward 
network is the most common topology, where it consists of a connection between different neurons that are directed 
only in one direction (forward) from the earlier stage to the next level. Recurrent or feedback network topology 
involves at least one feedback loop in the architecture [94]. Both of these network topologies have been successfully 
employed in modeling and for the prediction of BG levels in type 1 diabetes patients. Regarding the feed-forward 
network, for example, Allam et al. and others [18, 44, 45] have developed a feed-forward neural network from CGM 
data using the back propagation Levenberg-Marquardt optimization training algorithm. Pappada et al. and others [46, 
47, 65] have also proposed time-lagged feed-forward neural networks trained through a back-propagation gradient 
descent algorithm, which is capable of storing previous values of data within the network. Zainuddin et al. [29] have 
proposed a wavelet neural network, integrating different wavelet families as an activation function for modeling BG 
dynamics trained through pseudo-inverse with fixed parameter initialization. Zarkogianni et al. [27] developed a 
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seven-layer neuro-fuzzy network using wavelets as an activation function and Gaussian function as a membership 
function trained through a gradient-based algorithm with an adaptive learning rate. Compared to these shallow 
networks, Mhaskar et al. [52] proposed a semi-supervised deep learning neural network with a judge predictor based 
on the function approximation on data-defined manifolds, using diffusion polynomials. Baghdadi et al. [19] 
implemented a radial basis function network using Gaussian function in the hidden layer neuron. Georga et al. [57] 
investigated the applicability of an extreme learning machine (ELM), specifically an online sequential ELM (OS-
ELM) and online sequential ELM kernels (KOS-ELM) for training single hidden-layer feed-forward neural networks. 
In a surgical care setting, Pappada et al. [48] trained a feed-forward network from CGM data for bedside monitoring 
using a back-propagation training algorithm. Apart from the feed-forward network, recurrent or feedback networks 
have been utilized in BG prediction; that is, recurrent neural networks, autoregressive neural networks and self-
organizing maps. For example, Daskalaki et al. [22] developed an online adaptive ANN-based model using a fully 
connected, multilayered ANN with two feedback loops trained through a teacher-forced, real-time, recurrent 
algorithm. Sandham et al. [38, 42] and Robertson et al. [40] have used an Elman recurrent network trained through a 
backpropagation gradient descent algorithm with momentum and an adaptive learning rate and Levenberg-Marquardt 
algorithm, respectively. Alanis et al. [73, 79] developed an autoregressive version of a neural network called neural 
network autoregressive external input (NNARX), which is trained through an extended Kalman filter (EKF) algorithm. 
Chernetsov et al. [21] performed a comparative analysis of three recurrent or feedback networks: the layer recurrent 
network (LRN), Elman net, and nonlinear autoregressive network (NARX-net). They investigated the effect of 
different learning algorithms, network architectures, prediction horizons, data sample sizes, and tapped delay line 
lengths on the performance of the network. Moreover, Zarkogianni et al. [26] conducted a comparative analysis of 
four machine learning techniques in the modeling of BG dynamics: a feed-forward neural network (FNN) trained 
through a backpropagation algorithm, a self-organizing map (SOM) achieved by applying a vector quantization 
method, a neuro-fuzzy network using wavelets as activation functions (WFNN), and a linear regression model (LRM). 
They used CGM data and also explored the effect of physical activity data collected from a SenseWear Armband. The 
study demonstrated the superiority of SOM and its ability to capture both the complexity of the dynamics and also the 
inter- and intra-variations among the patients [26].  
5.2.2. Support Vector Machines (SVM), Kernel Function (KF), and Gaussian Process 
Regression 
Support vector machines have been widely exploited across a wide range of applications, such as pattern identification 
and recognition, categorization or classification, regression, and prediction [95]. Support vector regression (SVR) is 
the most widely used class of SVMs in BG prediction and modeling. In this regard, for example, Reymann et al. [41] 
investigated the applicability of BG prediction using a mobile platform based on SVR, with radial basis function 
(RBF) as a kernel. Moreover, Li et al. [54] tried to use pooled patient data to capture patient similarities, which led to 
the development of a personalized BG prediction model using smartphone-collected data based on SVR. Georga et al. 
[58] investigated the potential performance enhancement from using a feature ranking algorithm, random forests (RF), 
and RReliefF algorithms, where the predictor is based on an SVR-exploiting Gaussian radial basis function (RBF) as 
a kernel. 
As a solution to the artificial neural network requirement of larger training data and much more information to learn, 
Naumova et al. developed a novel fully adaptive regularized learning (FARL) approach using meta-learning to choose 
the kernels and regularization parameters in kernel-based regularization learning algorithms [35].   
Gaussian process regression is a useful nonparametric regression tool that has been widely adopted in various 
applications, such as a vital-sign “early warning system,” patient physiological monitoring, disease prediction, and 
the discovery of biomarkers in microarray gene expression data. Tomczak et al. [32] investigated the applicability of 
Gaussian process regression in BG prediction coping with categorical inputs. The input consisted of the data, time, 
code (categorical), and BG level (numeric). The categorical code was used to describe the type of measurement (e.g., 
insulin dose, meal intake, physical exercise, pre-prandial BG measurement, and others). The covariance function was 
proposed to deal with the categorical inputs [32].  
5.2.3. Genetic Programming and Genetic Algorithms 
An evolutionary algorithm (EA) is a biologically inspired approach to problem solving [96]. The two most used 
variants of EA in BG prediction and modeling approaches are genetic programming (GP) and genetic algorithms 
(GA). Hidalgo et al. [76, 77] used a genetic programming-based symbolic regression known as grammatical evolution 
to develop an individualized model of BG dynamics. Moreover, Contreras et al. [71] used the grammatical evolution 
approach to develop a standalone BG prediction model. Furthermore, Hidalgo et al. [69] assessed the performance of 
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different predictors, genetic programming, random forests, k-nearest neighbors, and grammatical evolution along with 
a new enhanced modeling algorithm, a variant of grammatical evolution that uses optimized grammar, and a variant 
of tree-based genetic programming that uses a three-compartment model for carbohydrate and insulin dynamics. 
5.2.4. Random Forest (RF) 
Random forests or random decision forests are an ensemble approach of learning for classification and regression 
applications, which learns by constructing a multitude of decision tress generating the mode of the class or the mean 
of prediction. In this regard, for example, Xao et al. [30] developed a random forest regression and support vector 
regression-based BG predictors and assessed the performance improvement gained through the selection of an optimal 
feature representative using a combined approach of feature importance scores of ensemble learning and a sequential 
backward selection (SBS) algorithm. Furthermore, Georga et al. [59] used a random forest regression to predict BG 
levels with a multivariate dataset containing a subcutaneous glucose profile, plasma insulin concentration, intestinal 
absorption of meal-derived glucose, and daily energy expenditure. 
5.2.5. Hybrid Approach  
Hybridization involves combining two or more different approaches, either at the preprocessing, feature extraction, or 
learning stage when looking for improved performance. The majority of the BG prediction models involve the 
hybridization of physiological (compartmental) models along with different machine learning techniques. Regarding 
support vector regression, for example, Plis et al. [43] combined support vector regression along with a physiological 
model, where the latter generates informative input features to be used to train the SVR model. Furthermore, Georga 
et al. [60-63] combined support vector regression with compartmental models, which are used to quantify the 
absorption of subcutaneously administered insulin, glucose from the gut following a meal, and the effects of exercise 
on plasma glucose and insulin dynamics. Regarding the hybridization of an artificial neural network with other 
approaches, some researchers have reported success in this direction. For example, Mougiakakou et al. [50] combined 
an artificial neural network with a compartmental model, where the latter is used to estimate the effect of food on BG 
levels and the influence of injected insulin on plasma insulin concentration; this output along with the previous BG 
measurements were used to train the ANN model. Mougiakakou et al. [51] further investigated the combination of a 
recurrent neural network along with three compartmental models, which estimated the effect of short-acting (SA) 
insulin intake on blood insulin concentration, intermediate-acting (IA) insulin intake on blood insulin concentration, 
and, carbohydrate intake on BG absorption from the gut. Zecchin et al. [23, 24] combined an artificial neural network 
and a physiological model to exploit meal information to be used along with the CGM data. Moreover, Zecchin et al. 
[15, 25] further explored the applicability of a jump neural network, which is feed by a meal physiological model and 
CGM data, and compared their result with a previously proposed artificial neural network [23, 24]. Briegel et al. [74] 
explored a nonlinear state space model for modeling an individual BG dynamic using a compartmental model and an 
artificial neural network. Furthermore, Otto et al. [49] developed a hybrid model combining an artificial neural 
network and fuzzy logic, where the fuzzy logic was used to approximate food, insulin, and the level of exercise. 
Several researchers have attempted to hybridize genetic programming along with physiological models. For example, 
Contreras et al. [70] developed a hybrid model using a genetic programming-based algorithm known as grammatical 
evolution and a physiological model. Self-organizing maps (SOMs) have been used to develop a hybrid model along 
with a physiological model. For example, Zarkogianni et al. [28] used the physiological model to simulate the 
subcutaneous insulin kinetics and glucose absorption from the gut into the blood, which are in turn fed into the SOM. 
Jankovic et al. [56] developed a two-layer (prediction and correction layer) online adaptive personalized BG prediction 
model. The prediction layer consisted of an autoregressive model with external input (ARX) and an artificial neural 
network, which made the first estimates and then the output was further optimized in the second (correction) layer 
through an extreme learning machine (ELM). 
5.2.6. Ensemble Approach – Merging different Predictors for Performance Improvement  
Due to the complexity of BG dynamics, it remains difficult to achieve an accurate prediction in every circumstance 
(i.e., hypo/eu/hyperglycemia events). One prediction model can have a better prediction power in either of these 
circumstances, and the other model can achieve better predictive power where the first model fails to accurately 
predict. Therefore, it is natural to look for opportunities to exploit the strengths from these different predictors to 
achieve better predictive power in most of these circumstances, which has led to ensemble approaches. An ensemble 
approach is generally favored when one is interested in merging two or more different predictors for improved 
performance. Various approaches have been taken to ensemble predictors (e.g., heuristic algorithms; bagging, 
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boosting, and weighted majorities; the Bayesian model averaging approach, and online versions of these) [33]. The 
main differences between these approaches are how the weights are determined to achieve the best possible predictive 
power. In this regard, for example, Wang et al. [31] proposed a novel approach that is able to combine several 
prediction algorithms, where the adaptive weight of each algorithm is determined through an inversely proportional 
relationship to its sum of the squared prediction errors. The proposed approach was tested using an autoregressive 
(AR) model, an extreme learning machine, and support vector regression and achieved a satisfactory result [31]. 
Moreover, Stahl et al. [34] proposed a novel Bayesian approach to merge multiple predictors by using recursive 
weighting for a single prediction through a regularized optimization technique. Stahl et al. [33] further investigated a 
novel merging approach that combines elements from switching and averaging techniques to form a soft switcher in 
a Bayesian framework. Botwey et al. [66] investigated three different data fusion techniques to merge two predictors, 
an autoregressive model with output correction, cARX, and a recurrent neural network, RNN, based on the Dempster-
Shafer evidential theory (DST), genetic algorithms (GA), and genetic programming (GP). Moreover, Daskalaki et al. 
[68] merged an autoregressive approach with an output correction module (cARX) model, and recurrent neural 
network (RNN) models, where the fusion is implemented using a linear combination of the two models’ output and 
the balancing factor (weight) is determined through a customized cost function.  
Conclusion 
The purpose of this review was to assess and analyze the state-of-the-art machine learning applications in BG 
predictions pertinent to the controller of an artificial pancreas (a closed loop system), the modeling of a personalized 
profile, personalized decision support systems, and BG alarm event applications. Previously, a number of different 
approaches have been tested to develop a BG prediction model. However, due to the complexity of BG dynamics, it 
remains difficult to achieve a universal model that produces an accurate prediction under free living conditions and in 
every circumstance (i.e., hypo/eu/hyperglycemia events). Recently, machine learning has been used to address these 
tasks and has demonstrated to hold a promising future given the ever-growing availability of self-collected health data. 
The ubiquitous nature and widespread use of mobile health applications (mHealth apps), sensors, wearables, and other 
POC devices for self-monitoring and management purposes have made possible the generation of automated and 
continuous personal data, which have created an opportunity to use much more detailed data to better train the machine 
learning model. Various machine learning techniques have been tested to predict BG, such as, recurrent neural 
networks, feed-forward neural networks, support vector machines, self-organizing maps, Gaussian processes, genetic 
algorithms and programming, and deep neural networks. These techniques use various groups of input parameters and 
training algorithms. The main limitation of the current approaches is the lack of a well-defined approach to estimate 
carbohydrate intake, which is mainly done manually by the individual users and is prone to an error that can severely 
affect the predictive performance. Moreover, there is the lack of a universal approach to estimate and quantify the 
approximate effect of physical activities, stress, and infection incidence on the BG level. Almost all the studies have 
quite different approaches, and this poses a challenge in terms of regarding one approach as universal. None of the 
researchers have assessed model predictive performance during stress and infection incidences in a free-living 
condition, which should be taken into account in future studies. Furthermore, little has been done regarding model 
portability that can capture the inter- and intra-variations among patients. It seems that the effect of time lags between 
the CGM reading and the actual BG levels is also not well covered. However, in general, we foresee that these 
developments might foster the next generation of BG prediction, which should result in a great contribution in the 
effort to develop the long-awaited so-called artificial pancreas (a closed-loop system).  
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